|

- 积分
- 0
- 威望
- 0
- 包包
- 818
|
回复 chleiwu 的帖子: ?# R) f+ K- m* \. t! w
2 G# `& j y W( [; v& `4801 RESEARCH ARTICLE2 r* h& ~* f9 r6 L; L
INTRODUCTION
0 ~3 S6 L" P# yTranscriptional networks, signaling cascades, microRNAs and* _! x) k! u" p
other factors coordinately regulate stem and progenitor cell8 q9 g* m0 G& J1 y& p9 x X: b
populations to give rise to the mesodermal lineages (Davis and Zur# Z: E+ S$ @. _5 T- ?
Nieden, 2008; Ivey et al., 2008; Omelyanchuk et al., 2009; Park et
& e; L! D3 Z* C1 r, w. v. Fal., 1998). During embryogenesis, a set of anterior progenitors2 j: i b7 o5 i7 @+ ^5 B( I3 Y: E" K
coalesce to form the heart. These progenitors, along with the blood+ i8 f* ]7 o' \' ~8 A
and vasculature, comprise the circulatory system, which is the first
2 `* F1 F, |# |* I ^1 ?, A$ corgan system to develop in mouse and human. Disruption or& j8 ?- z' p, [7 K1 A
elimination of any one of these lineages results in early embryonic. X& y! `( g( c. g
lethality. However, the factors that regulate the co-emergence of/ t2 f8 ]7 t7 A7 J f6 S/ Y E
these lineages from the mesodermal progenitor pools are7 G0 {) E# w( q4 ^
incompletely defined.
1 S7 ~& r1 W }7 c, ^* z" IRecent studies have identified a multipotent progenitor cell. h9 ?# q0 f6 n# n+ s
population that is capable of giving rise to the cardiomyocyte and
, H( l, l( S' @& W4 Fendothelial lineages during embryogenesis (Kattman et al., 2006;' v& k* |) N0 n8 k! ~1 j
Moretti et al., 2006; Wu et al., 2006). Although these multipotent0 r2 {6 B/ U0 N: P: w
progenitors have been identified based on the expression of Flk1
$ v& a$ D7 r a7 P! Y4 b' n9 ~(also known as Kdr), Nkx2-5 and Isl1, the transcriptional networks6 m6 \" h' Y/ ]/ r. r2 O+ r S+ j
that govern the fate of these progenitors are unknown. These and
2 Y& s" a$ M& Q2 {3 m/ t2 `! wother studies emphasized the plasticity and context dependence of1 f# b9 |5 l7 p# D
regulatory cascades in the progenitor cell populations. For example,' U" Q4 w, Z8 _" l! w7 F8 @
our previous studies demonstrated that Nkx2-5 has a dual
1 o# Y. K4 F- e- C& m! ctranscriptional regulatory role in the promotion of the cardiac
4 I6 \ C: D0 Tlineage and suppression of the hematopoietic lineage (Caprioli et( S$ T5 t9 f3 |5 b" W4 w h
al., 2011). In this fashion, we proposed that the stoichiometry of) N1 |& q/ C5 K- E" y5 x, ]1 Q& i$ A
regulatory transcription factors and interacting factors could; b! `8 \* U' r
dynamically regulate the fate of progenitors. Definition of
+ J& ^$ J: \( [! ^+ V9 g7 nadditional networks and signaling pathways that promote and9 K, \. g8 O# q& X+ R, K7 C! F
suppress the fate of distinct lineages that arise from multipotent/ _6 I; s; w- f, O% B1 \ r
progenitors will enhance our mechanistic understanding of their
3 _8 m0 z3 p) k; ?" |$ X& ^0 W7 Ddevelopmental potential.& @0 `8 u5 C; m$ ^
Ets-related protein 71 (ER71; Etv2) is a member of the Ets; t8 z9 N; j- K) L' Q7 w7 Y9 V% v
transcription factor family that we and others have shown to be
~+ }" n, m8 U% L8 K3 gessential for formation of the endothelial and hematopoietic
$ g I* S3 P" b( k- K! |9 Nlineages (De Val et al., 2008; Ferdous et al., 2009; Lee et al., 2008).+ h0 X8 M( k# f5 _2 h
Er71 can be induced by BMP, Wnt and Notch signals to promote
8 F1 g- V& k: ] f9 j8 chematopoiesis (Lee et al., 2008) and synergizes with FoxC2 to
8 T2 v( { y0 iregulate the endothelial program by directly targeting Scl (also1 [. a/ u% \- y# U0 [
known as Tal1), Notch4, Cdh5 and Tie2 (also known as Tek) (De9 E# y) P3 u# K3 Y1 Q& l
Val et al., 2008; Ferdous et al., 2009; Lee et al., 2008). In Er71
7 a2 X4 i. c8 L$ f/ ymutant mouse embryos, there is a complete lack of hematopoietic
( E/ `/ R3 i) H. F& |+ Z4 C5 iand endothelial lineages and the embryos are nonviable by+ j* ?* T/ b& Z( U+ `% W
embryonic day (E) 9.5 (Ferdous et al., 2009; Lee et al., 2008).9 e: Y$ v; o0 ]( \
Analysis of the Er71 mutant embryos revealed no differences in
7 _( Y i D" o! m+ [' scellular proliferation or cellular apoptosis compared with age-
% H$ c$ x' k8 Z- c1 p# K3 Omatched wild-type littermates (Ferdous et al., 2009). These results, x [, y& t% d+ @, s+ Z
raised the question of whether the hematopoietic and endothelial
k9 c9 Q; U: U+ @' K, I3 y ]' Tprecursors are still present but unable to differentiate to hemato-! k+ q' o% Q0 ~! Y
endothelial lineages, whether they had been redirected towards% B+ z4 P7 `9 w( n0 t& }
other lineages or whether these cells never arose during
$ H ^3 C* V0 ]1 cdevelopment.
W! J5 Z$ \* v: ~Development 138, 4801-4812 (2011) doi:10.1242/dev.070912
" o+ D$ D3 g9 m/ }© 2011. Published by The Company of Biologists Ltd
* m. L& T0 l' U' @* E6 S$ H1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.! `' b* {+ v; M
2Department of Integrative Biology & Physiology, Medical School, University of7 h; y: t- A, a5 ]7 O( x
Minnesota, Minneapolis, MN 55455, USA. - ]$ l" ?4 `0 G/ d. Z" N7 G$ K
3Biolead.org Research Group, LC% y6 H% z, k! h9 `$ p
Sciences, Houston, TX 77054, USA. + g+ l# z: o, m( \/ y
4University of Texas Southwestern Medical
) T, R% Z! Z3 i( u$ B& j9 sCenter, Dallas, TX 75244, USA.2 H: J3 M7 m' P' H$ l: N
*Author for correspondence (garry@umn.edu)
2 I% P5 Q2 `& t. |6 _Accepted 5 September 20118 G% g u" X: L$ j' K" N# [
SUMMARY
9 ]9 o! H! Q( o) K7 v; a6 [7 ?/ ]Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for
z3 w, z p' z$ j# `/ g" _ }6 yER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse
+ q$ _8 W& I" p6 Pmodel by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the
: K3 D' n& |& v LEYFP+ population of cells in Er71 mutant and wild-type littermates. In the absence of ER71, we observed an increase in the& V K- b1 H- f8 f( P7 u
number of EYFP-expressing cells, increased expression of the cardiac molecular program and decreased expression of the hemato-
4 h" g7 z* `; k% T0 mendothelial program, as compared with wild-type littermate controls. We also generated a novel Er71-Cre transgenic mouse" Q+ X" j( }, O* r% c* s4 X
model using the same 3.9 kb Er71 promoter. Genetic fate-mapping studies revealed that the ER71-expressing cells give rise to the
% y; P1 B5 `$ m1 n- t B. Phematopoietic and endothelial lineages in the wild-type background. In the absence of ER71, these cell populations contributed$ h; S1 N" w4 I( _
to alternative mesodermal lineages, including the cardiac lineage. To extend these analyses, we used an inducible embryonic2 K2 }* ]) U+ g
stem/embryoid body system and observed that ER71 overexpression repressed cardiogenesis. Together, these studies identify ER71
# e# s M, F, zas a critical regulator of mesodermal fate decisions that acts to specify the hematopoietic and endothelial lineages at the expense
+ H/ d M2 u$ [% j# W4 ]of cardiac lineages. This enhances our understanding of the mechanisms that govern mesodermal fate decisions early during
* Q; a% i/ m7 ^embryogenesis.
! k& Y0 a( x% ~% qKEY WORDS: Transgenesis, Er71 (Etv2) knockout, Mouse t2 j" J- I1 L% l0 j. z0 g6 S
ER71 directs mesodermal fate decisions during
) u% C3 H6 L2 R5 L( o0 Rembryogenesis# }: ]5 ^4 r3 F( d4 G# |
Tara L. Rasmussen1, Junghun Kweon1, Mackenzie A. Diekmann1, Fikru Belema-Bedada1,2, Qingfeng Song3,
6 Q$ ?$ { E% [9 w! z7 G0 I1 XKathy Bowlin1, Xiaozhong Shi1 d! Z9 G3 v, x
1, Anwarul Ferdous4, Tongbin Li7 q1 s; Y, p. o
3, Michael Kyba1, Joseph M. Metzger1,2,
* X6 T$ e& s5 _: s& c. FNaoko Koyano-Nakagawa1 and Daniel J. Garry1,3 R3 m; R2 O7 Z; D! ?" O; e' D
*
, x/ M4 u' H& h. FDEVELOPMENT4802% e: B: x! Q! t
In the present study, we have dissected ER71-mediated
) T% N5 v2 w9 f& m! emechanisms that govern fate determination during murine
' y/ W- _' ^7 i8 O3 Nembryogenesis. We have generated a novel transgenic mouse) J4 s6 Q) m3 w/ L9 s K& N
model in which the 3.9 kb Er71 promoter drives the EYFP reporter
1 O: @: B5 y/ V+ W- h# ](Er71-EYFP), and crossed it into the Er71 wild-type and mutant
0 |/ h; I$ Q4 P5 F" ?0 z8 nbackgrounds. This strategy facilitates the isolation and
. Z6 w% ?2 p! f7 v: u/ V; V4 |characterization of cells that would normally express ER71 from
' V" V' W* c7 x3 N" ^9 W3 W2 wEr71 mutant embryos. In the absence of ER71, we observed the5 `. w" E- \9 Z* B
conversion of cells that would normally give rise to lateral plate# S a# A# q) ]3 E' H
mesoderm into cells that produce paraxial and cardiac mesoderm.. ?' {( K% e& \
Furthermore, ER71 overexpression in vitro using an inducible7 H& |) g: w; E9 d
embryonic stem cell/embryoid body system demonstrated O: Z) X5 a1 U: _) d
decreased cardiogenic potential. Collectively, these data
7 P8 K* G8 N3 _2 s# V/ J: zcomplement and extend our understanding of the functional role of
4 d9 s, C! N2 f9 }ER71 to differentially promote mesodermal fate decisions during
k+ \- _: |# D5 b# Dembryogenesis.
2 Y. z: z" Z' Y n( e! d) [- {' yMATERIALS AND METHODS
) S- l* |: Y; ?# a# sGeneration of transgenic mice
! A3 R- k: h( o& }! \' WThe 3.9 kb Er71 promoter (Ferdous et al., 2009), which harbors the
5 a1 M6 w3 `2 w7 zmodules necessary to direct the temporal and spatial expression of ER71,. h2 [9 |- N3 O: D) e3 q' R9 E" ]
was cloned into the pEYFP-1 vector (BD Biosciences) and into a2 f/ N8 J" P: D9 @' r% A
promoterless pBS-Cre-pA vector to generate the ER71-EYFP and ER71-
. g6 E, i% Y& X" e+ MCre constructs, respectively. Transgenic animals were generated at the
1 N9 Y" A. b7 A2 W5 q, kUniversity of Minnesota Mouse Genetics Laboratory using standard& `: `) J% W! o5 C) P. H# _
methods. Transgenic mice were screened for DNA integration by PCR. X# d8 z- ^* B4 S$ v2 Y
Expression analysis of ER71-EYFP lines was performed by examining
& p' L% b Q3 W( Q+ U6 {* `E7.0-9.5 embryos resulting from timed matings to wild-type CD1 mice
8 T3 A/ V+ ^+ }) v2 ^- E5 T(Charles River). We also analyzed E11.0 and postnatal day (P) 3 offspring
B! p! U) I4 A# `of timed matings of the ER71-Cre lines and the Rosa-EYFP line (Jackson) n- [) @9 k* s- r
Labs 006148). Founder mouse lines were crossed to the Er71
' {4 A( Y+ ~* r2 qheterozygotes previously described (Ferdous et al., 2009). In all cases, at
, h9 j; |) f1 B% Z4 _2 C; z% mleast three transgenic lines were examined to confirm similar temporal and
2 s9 o2 V. a/ @0 q8 `) zspatial expression patterns. All mice were maintained at the University of3 D0 J8 e( o4 ]4 C1 B: j
Minnesota under protocols approved by the Institutional Animal Care and
^1 |5 ~; v! S+ X0 Q+ m( iUse Committee and Research Animal Resources.9 y9 R- ^8 m) M! N1 U; o8 ^* f
FACS analysis
& u! s! P j4 G) l1 IEmbryos from timed pregnant females were harvested at specified stages.
4 k2 U; X7 g2 R7 n N+ _Embryos were separated from yolk sacs, which were used for genotyping,
1 x j5 M$ }" E& Xand imaged on a Zeiss Axio Observer Z1 inverted microscope prior to
" P- O& U% N/ Zdissociation. Embryos between E7.5 and E9.5 were digested in 30-50 l
$ D4 W$ t1 U" I& o& v0.25% trypsin plus EDTA at 37°C. Digestion was arrested with 500 l) ^; u$ @ A' d# U: _$ J2 I, m
DMEM containing 10% fetal bovine serum (FBS). Cells were pelleted at3 l0 \. A% K: w0 p- U2 w
4°C (1600 g), resuspended in PBS and passed through a 70 m cell
. F5 s4 f: P7 ~& B: M( ?strainer. Cells were incubated with antibody cocktails for 30 minutes,
d# Y+ i3 M* Q8 f8 r+ owashed, and resuspended in PBS. Cells were analyzed or sorted using a+ `) O, K8 Y* D/ B8 I5 s1 @# T, U
FACSAria (BD Biosciences). Various combinations of antibodies (1:1000)3 W4 d, D$ i, W! L8 J: K8 b
were used, including Flk1-APC (eBiosciences 17-5821), Pdgfra-PE' N" ~( Z$ M& Q% T
(eBiosciences 12-1401), CD31-PECy7 (eBiosciences 25-0311), CD34-PE9 X5 f( Q/ g( j/ P. P, v
(BD Pharmingen 551387), cKit-APC (eBiosciences 17-1171), CD41-' Y' H; \! J' l9 }% q
PECy7 (eBiosciences 25-0411), CD45-PE (BD Pharmingen 553081),
4 _' @. }, i3 A/ G0 s' l2 Q; pCD45-PECy7 (eBiosciences 25-0451-81), and Ter119-APC (BD( y: }& |3 b8 K
Pharmingen 561033) antibodies.
; N5 c/ a+ ]1 A0 S2 y. B$ F7 STranscriptome analysis
) A- g; P* n5 l H2 H% C8 qTotal RNA was isolated from 1000-5000 FACS sorted cells in TRIzol+ w& c2 ~ W1 U: M$ i4 ?
(Invitrogen) using the PureLink Mini RNA system (Ambion). RNA was
0 F( D% `$ k' s2 S; X* A! Zsubjected to two rounds of amplification using the MessageAmp II aRNA- ]1 L' k, g$ e! \- @; l4 f' q
Amplification Kit (Ambion) and then labeled using the MessageAmp II-# x) x" W4 i, R5 m) }
Biotin Enhanced Kit (Ambion) according to manufacturer’s protocols.& G- \' s0 I/ u
Amplified RNAs were hybridized to Affymetrix mouse 430 2.0 full genome
8 [ ^6 U3 z r) z1 R, D! {array chips at the BioMedical Genomics Center of the University of
2 }8 g2 o+ `, C3 p- H+ ZMinnesota. The CEL data files produced from Affymetrix array experiments
+ c! Q5 L) I9 j, [were processed using the affy package included in Bioconductor. The robust4 m( b2 z ^ t0 K4 t9 M& I G
multi-array (RMA) method (Irizarry et al., 2003) was used to perform data! }0 W4 C: w. |$ s' ^6 C
normalization, background correction and expression quantification. The
4 A0 D# g. f) a0 |3 Ylimma package (Smyth, 2005) was used to identify differentially expressed1 w+ r% r5 p$ K
genes by ANOVA analysis, and false discovery rate (FDR) values were
& a! q3 f a( U/ x# ]. hcalculated using the Benjamini-Hochberg method (Benjamini and Hochberg,: Z6 D! y: `& }# W+ d
1995). Average linkage hierarchical clustering analysis was performed using
9 p$ }+ S) c0 `! `the cluster program (de Hoon et al., 2004), with uncentered Pearson’s; a+ u8 V w$ p4 K& q2 @
correlation coefficient used to define pairwise similarity in gene expression.% d6 _4 `7 Z3 g: A
Genes annotated with the gene ontology (GO) term ‘heart development’# w" Q# f& y0 b, X8 {: U
(GO:0007507) were downloaded with AmiGO tool (Carbon et al., 2009) and
1 W$ j* @* _# f0 N8 }% `0 X! c) n+ Aused in producing the heatmaps. Microarray data is accessible in Gene' O, l; S. H6 ^# F
Expression Omnibus (series GSE32223).$ A& j+ z1 \) W7 ]
Quantitative RT-PCR
% C. Q1 G) a- i" dTotal RNA was isolated from 1000-5000 FACS sorted cells or embryoid
+ ]6 i, N- M6 r" L) }' jbody cells in TRIzol (Invitrogen) using the PureLink Mini RNA system.
* Z% b+ m; f, ?$ BRNA from FACS sorted cells was subjected to two rounds of amplification8 }4 p, O6 z& ?
as described above, but left unlabeled. cDNA was made using random. I5 t! h! |9 l# W3 \! `8 b1 b
hexamers and transcript levels were determined using VIC-labeled (Gapdh,
h \ b, x* T5 A9 g4352339E) or FAM-labeled (Er71, mm01176581_g1; Scl,
9 a' `3 R0 l( i( D1 Lmm01187033_m1; Cdh5, mm00486938_m1; Gata4, mm00484689_m1;- o6 L" \- v: n5 q# R( z8 W
Tbx5, mm00803518_m1; Tnnt2, mm00441922_m1) TaqMan probe sets
* [1 ~, l2 ]- s8 H, c6 I(Applied Biosystems).
& o" v# H' d! C( {8 hEmbryoid body differentiation and ER71 overexpression
" y: o6 l" z6 t* b3 wDoxycycline-dependent ER71-overexpressing mouse embryonic stem
6 u5 x, h' Z# j/ t3 C: Z(mES) cells were generated using an inducible cassette exchange strategy& J& F* p% W3 I; Q2 U3 G
(Iacovino et al., 2009). In this system, ER71 tagged with a C-terminal HA
" m: M/ P: [" e& ]% Z0 Bepitope was overexpressed in response to 0.5 g doxycycline. To mimic
3 ]/ J; \/ D1 o/ L& w: M# T" E0 [2 p8 learly embryonic development, the mES cells were differentiated into
0 P% Y4 x9 B; F8 [0 Membryoid bodies (EBs) using mesodermal differentiation media [1.5% FBS1 Z9 i2 b1 M1 H( r& P2 @
(Stem Cell Technology), 1 penicillin/streptomycin, 1 GlutaMAX
' Z9 d. T2 `% C8 Y$ K(Gibco), 100 g/ml Fe-saturated transferrin, 450 mM monothioglycerol, 50
5 @7 G& F# o1 }) ~1 B! \6 Eg/ml ascorbic acid in IMDM (Invitrogen)] (Kennedy et al., 1997). ER71* f9 c7 G9 ^* E& M
was induced on day 3 after initiating differentiation and maintained through; h" r$ |+ p& X
day 10 by supplementing the differentiation media with doxycycline. On, Y+ |# o* b4 ] W) j
day 10, we fixed the EBs with 4% paraformaldehyde (PFA) and prepared+ c4 d4 V$ W5 }2 d4 ?, N/ T ^, ^
cryosections. We stained adjacent sections with Hematoxylin and Eosin
. z h3 u3 m( x! {5 Y* E, Fusing a standard protocol and performed immunostaining with mouse anti-
+ J6 A; Z/ s% TTnT serum (1:200, DSHB clone CT3). We assayed the TnT-expressing area
1 H/ ^: T# L* o4 ~( O3 Y) [% j! s: Yof each EB using ImageJ software (NIH) and calculated the ratio of the
8 }2 D6 b2 q9 {7 O$ Upositive area to the total area from 33 sections of uninduced EBs and 42
4 C4 z4 q! t3 g+ A8 q; K: Tsections of induced EBs. EBs were placed on laminin-coated coverslips
/ l6 Y8 E! ^5 N" hand stimulated at 1 Hz. Edge detection (Ionoptix, Milton, MA, USA) was6 x; |* \5 f, w5 B1 W! u2 y6 Q3 x
used to measure contractility of intact EBs.% [1 e! W! l: E8 l( A( W
Immunohistochemical analysis3 i" N- {' P2 i3 Q
Stage-specific embryos were harvested from time-mated pregnant females.
+ r4 j2 |' B3 U. t7 \. g+ ]+ DFor paraffin sectioning, embryos were fixed for 4-8 hours at 4°C in 4%* k+ ]0 a0 ?5 x- P8 A' J" A
PFA and embedded. For cryosectioning, embryos were fixed for 1 hour at* \1 q4 V% A0 H* q) S
4°C in 4% PFA and embedded in OCT compound (Sakura). Sections were
/ \# o: E( n9 I% ~* q/ Z# _9 P) ]% k( Pblocked with immunohistochemical diluent (2% normal donkey serum, 1%
6 q i& A, I! u* d# abovine serum albumin, 0.3% Triton X-100, 0.02% sodium azide in PBS, W, n% x2 Q' t" U, z
pH 7.3) at room temperature and incubated overnight at 4°C with primary5 F0 t8 G! x1 R* y* z; ]
antibodies, including chicken anti-GFP (1:500, Abcam ab13970), rabbit, C9 ] ]) ?$ b$ Y& D) k& K
anti-desmin (1:200, Novus Biologicals NB120-15200), rat anti-Tie2 (1:100,/ @9 x1 q2 E F
eBiosciences 13-5987-81), rat anti-Pdgfra (1:200, eBiosciences 12-1401-
1 Y3 {/ g2 n- \6 b# |% t: t81), goat anti-Nkx2-5 (1:500, Santa Cruz SC-8697) and anti-CD41 (1:100,
, W9 y6 p: S' F0 bBD Pharmingen 550274), anti-Cdh5 (1:100, BD Pharmingen 55289), anti-" G2 {% Y3 _' x. o* b% y8 y2 N
CD31 (1:200, BD Pharmingen 550274), anti-Gata1 (1:100, Santa Cruz SC6 A8 y J; X V4 V1 W+ ?
265X) and anti-troponin T (1:200, DSHB CT3) sera. Slides were washed
& o w! y7 E- a9 B+ C+ E0 e$ fand incubated with combinations of secondary antibodies (1:200) including
2 y4 N2 ~0 n& m+ [9 X1 panti-chicken Dylight 488, anti-rabbit Cy3, anti-mouse Cy3, anti-rat Cy30 R: l0 D& d' o3 a" K
and anti-goat Dylight 549 (Jackson ImmunoResearch Laboratories).+ ~: W, m' Z7 Q- N. P e, P
Results were imaged on a Zeiss Axio Imager M1 upright microscope or a
3 W" Y) O2 K3 [) t( ~; OZeiss LSM 510 Meta confocal microscope.5 G+ I9 X3 u' E' z( l9 p5 Z" L# l# U, `
Statistical analysis
0 K# S% f" i7 u3 N* ^Data represent the average of at least three replicates and s.e.m.# u$ ^4 t, J" q; D
Significance was tested by the Kruskal-Wallis test with the Dunn multiple4 M$ J6 G# ~/ u7 X/ T6 g. V
comparison test for more than two groups; for example, when comparing
2 W9 T5 [1 E2 l# vRESEARCH ARTICLE Development 138 (21)
3 X, i& t/ v, N' o0 K+ dDEVELOPMENTwild type, heterozygous and homozygous mutants. Significance was tested5 x O) j% p& i. i% A! b' ]/ U
by the Mann-Whitney U test for two groups. Analyses were performed
: l- ^& R+ @ L6 rusing Prism5 software (GraphPad).
& t- ]9 _% _& ?4 b& I* X9 y# d! U! TRESULTS) y; C [! b( m8 s4 Q
Expression analysis of the ER71-EYFP reporter
6 \; {' ~' F6 H/ _Initial analysis of ER71 expression in the developing mouse4 M f2 x$ H/ f: t
embryo was reported previously (Ferdous et al., 2009; Lee et al.,
$ g- k' f7 q/ W) R2 g2008). To further examine its potential role in cardiovascular4 G+ l& c/ \" q! h8 k, Y5 ]9 C
development, we performed a detailed expression analysis of ER71
3 I8 J5 ]- \7 S( ofrom E7.0 to E9.5, when Er71 mRNA is expressed (Ferdous et al.,
' Q& q# R* f8 [, @* Q3 s9 ^7 w2009). None of the commercially available ER71 antibodies
% J- p" S+ l( Pdetected the endogenous protein, so we utilized an Er71 transgenic# o8 j" [4 n! M* E' D
mouse driving an enhanced yellow fluorescent protein (EYFP)
1 I: \% ~1 D$ d" @- E! rreporter. The 3.9 kb region upstream of the Er71 transcription start3 N2 L4 Y1 q$ {. p; J# T( G) x
site was fused to the EYFP reporter (Fig. 1A). This promoter4 m% e' G1 B8 {; B( g( T4 O+ f7 L
fragment was previously shown to drive reporter expression that
. k/ f' X- f4 Q* A- B$ o" Brecapitulated endogenous ER71 expression (Ferdous et al., 2009)., ]1 W$ U) n7 D r& V$ O7 F5 `
Four founder lines were generated with offspring embryos that
T0 L6 d1 N. ~* wshowed the same expression pattern.
- \& R! n8 c YTo examine the expression pattern of the EYFP reporter, we9 E, P+ r4 o6 i. H' V8 L
compared its expression to that of the angiopoietin 1 receptor Tie2, L; l. A% F6 ]& r8 K5 d3 d1 y+ v4 Z
which marks endothelial cells in mice and humans (Dumont et al.,
- n; ~4 T1 Z# I5 j6 `1992; Sarb et al., 2010; Schlaeger et al., 1997; Schnurch and Risau,% S- y @. `' Z$ w
1993). The EYFP reporter (representing ER71 expression) was4 a# z, ^% T$ X& P
expressed as early as the early to mid gastrulation stage (E7.0; Fig.
9 x% M" w% b3 J0 d3 b. n1B, bracket). At this stage, reporter expression was limited to the- n0 {9 K6 x9 Q! X: ?( q
extra-embryonic mesoderm (Fig. 1C) and showed co-expression
6 ?& m" W' Q0 ~, ]4803 RESEARCH ARTICLE ER71 governs progenitor fates1 c( g# }7 O+ V) B, J: l* l
Fig. 1. The transgenic ER71-
; k& R* L- L6 L! s5 ~% G/ EEYFP reporter is expressed
4 h+ e4 x" x. A) B0 \during embryogenesis.$ ]' x4 I D: X( Z+ i) L' ]
(A)The transgenic Er71-EYFP+ e0 K5 i4 P+ O9 Y" L& v( M" {& K
construct used in these analysis.
2 e- U1 t% h% j1 x8 x(B-Q)Expression analysis of mouse/ ?3 \* \+ @3 @( @+ q0 B
embryos between E7.0 and E9.5.
5 O( S! r+ y, G. a- |2 O0 LEYFP protein fluorescence (green)
" V( B1 W, b* P+ \: w: U2 j2 D7 vis shown in whole-mount images
' p% Z \% E; x1 o* e(B,D,F,J,K,N). Sections were
# i: a ^1 x9 `9 K _4 qstained with anti-GFP (green)," b; U+ }$ L1 _; j; @- u: Y
anti-Tie2 (red), anti-Nkx2-5 (red)
+ a" h* ?6 j( P# L5 O- dor anti-Pdgfra (red) antibody as/ I& y3 {8 }+ S/ |! \' c& X
indicated. DAPI nuclear staining is
' d; P3 G8 @/ N3 Hshown in blue. Yellow indicates
7 i) S z2 `8 Woverlap of green and red& F. l- x3 s4 ?' r8 h: M
channels. (B-C) Early to mid
0 P+ _) D2 f+ A `, wstreak stage, (D-E) early bud/ d9 A; Y& s/ |& s
stage, (F-I) early head-fold stage,
; }0 S, z$ D e# c(J-M) E8.5, (N-Q) E9.5; embryos
a2 a* w1 P( b, u1 t& M1 t3 M' hwere staged according to Downs
# M, }: ?- A: t% J1 xand Davies (Downs and Davies,
: J, l6 R. @5 _" ]! A1993). Boxed regions are shown
+ a2 e& e; U4 E7 j; n2 J) tat higher magnification; planes of
6 ~3 Q8 U, O5 W% }sections are indicated. See first9 i# n: J1 i( h( I. l1 s
section of the Results for a
, r @, G" \" c: x8 z4 w3 H7 M* ?description of arrows, arrowheads
$ t1 l( b/ j8 \. z: y' J& p* I" sand other labels. al, allantois; ba,
4 u* t3 j5 b" z3 pbranchial arch; bi, blood island;
5 B" Y& l, l0 A* Y" zcc, cardiac crescent; cv, cardinal+ K/ _/ z+ w" j: e" r' G% ?& `0 s
vein; da, dorsal artery; ec,. k% E& ~4 R B5 |5 W
endocardium; h, heart; hf, head
2 _7 Y2 f2 P4 w8 M# o2 k/ Jfold; np, neural plate; nt, neural7 s0 Y3 z) x, l/ ^6 A
tube; ph, pharynx; pm, paraxial
3 E- C8 F3 P8 X$ V. z8 ?* `mesoderm; s, somite; ys, yolk sac.+ K! k! V) @: |/ d% H# P4 L6 w2 L
Scale bars: 200m; 50m in
: i, S4 t3 _& X7 A2 renlargements.- Q1 v- g: T4 Y
DEVELOPMENT4804$ l0 L; P3 N" t5 z/ g# o2 N
with Tie2 in the primitive blood islands (Fig. 1C,C, arrows) (Ema
! C, o) X! z, w! p6 X! Z% {5 ^; \% {et al., 2006b). EYFP was also weakly expressed in the mesothelial n6 ?# y7 ]7 R3 L
layer of the yolk sac, but Tie2 was absent in this non-endothelial3 A+ a% r+ L, u8 r# |
cell population (Fig. 1C,C, arrowheads). At E7.5, continued
9 w) L9 C6 [ g; q6 i; Yexpression of the EYFP reporter was observed in the extra-/ q2 d7 I3 ^" @6 O. N2 l! \* I" x2 }
embryonic mesoderm (Fig. 1D, bracket). In addition, scattered; `7 V6 V: N- Y0 m7 V
EYFP+ cells were observed in the lateral plate mesoderm (Fig. 1D,
# [$ |0 P% X' K" r, garrows). Transverse sections showed that these scattered cells co-
p- Y/ {. X" j" e! W8 f4 B0 Uexpressed Tie2 and most likely represent endothelial progenitors3 U4 V/ d& v5 }. q
(Fig. 1E,E,E), although Tie2 expression has also been identified
. L* C: O. F6 P2 o" Bin a subset of cells committed to the hematopoietic lineage* ^. ]( }8 ^" M$ c d
(Kisanuki et al., 2001; Li et al., 2005).
5 M' T) ]- ^0 ^( k( g: sAt E7.75, the EYFP signal localized to discrete structures
, t& D, o8 I/ p$ {- Y# e9 `. ]including the cardiac crescent and the progenitors of the dorsal aortae) ]6 G+ j' Y. H0 Z! g
(Fig. 1F, cc, arrows). We examined the expression in the cardiac
2 U9 W1 r1 U8 a- e+ Y' d! h) `crescent and paraxial mesoderm in detail using Nkx2-5 and Pdgfra
# s+ D. F; X& O2 Y+ s( wantibodies (Fig. 1G-I). We observed that the EYFP signal overlapped7 a; X& d$ A$ P0 w5 J. ?' l5 {/ H; B5 _
extensively with Tie2 within the cardiac crescent (Fig. 1G,G).
' ~( Z" U7 c- e# k! G( T0 lThese EYFP+ cells are presumably endocardial progenitors (Misfeldt2 Y, |6 m0 w7 J6 j J
et al., 2009). By contrast, EYFP+ cells either weakly expressed or did
M- L1 ^& ]# l8 snot express Nkx2-5 (Fig. 1H,H, arrows and arrowheads,
% R# C: \# V# A+ b J3 ]respectively). We did not observe strong co-expression of Nkx2-5
$ V3 m! Z1 g0 Oand EYFP. Pdgfra is strongly expressed in paraxial mesoderm and5 q; w2 b! v7 e8 C0 d; _3 V, y; G4 Y
cardiac mesoderm (Fig. 1I, pm and asterisk). Double. e+ z( s7 g: u! F
immunohistochemical labeling of EYFP and Pdgfra demonstrated& B; n2 E0 E. ]- Q
that most cells either did not co-express these markers or weakly5 b3 d3 z7 U: H' c& h; I+ N
expressed Pdgfra (Fig. 1I,I,I, arrowheads and arrows, respectively),
# b9 f) Z+ ]# {8 ]- Swhich is consistent with previous reports that the hemogenic lineage
, D# I, n$ J4 U: E+ \is segregated from the paraxial mesoderm early during gastrulation* B* J0 D% `( E
(Kataoka et al., 1997; Takakura et al., 1997).9 J& l+ q$ |2 u$ E) _5 S% U3 t
At E8.5 and E9.5, we observed localization of the EYFP signal to2 \2 T; G% F/ }* N/ A4 R4 F
vascular structures throughout the embryo proper (Fig. 1J,N; arrows
; k L6 d7 M; g0 R4 w- Opoint to the dorsal aorta and arrowheads indicate intersomitic vessels)
/ Y/ a, t: q$ }7 J5 Qand yolk sac (Fig. 1K). Transverse sections of the embryos (Fig.
2 [! C6 D( E5 X1 S1L,M,O,P) showed localized expression in the vessel structures, X' E0 W5 o) F% K7 a1 M: v
including dorsal aorta, cardinal vein, intersomitic vessels! k0 w! |0 l8 |; h$ X
(arrowheads in Fig. 1M) and the endocardium (arrowheads in Fig./ r7 M0 l# S) A* {- {9 u! o/ @9 O
1L). The expression of EYFP largely overlapped with that of Tie2,( ^& c4 B6 } H' `; u$ z0 j
indicating that the Er71 promoter is active in early embryonic; q% u9 o2 y' H' _0 O/ o
endothelial and hematopoietic cells (Fig. 1O-P). We also observed
# ~* U$ Z8 ]- M0 Vthat EYFP was co-expressed with the hematopoietic transcription
$ B' p5 p1 I! W4 c2 `& Cfactor Gata1, the cell surface marker of hematopoietic progenitors; o$ O# ], w. E' Y6 U" W
CD41 (also known as Itga2b), the marker of hematopoietic and% E; l# y5 m( U( a
endothelial lineages Cdh5, and with the primarily endothelium-
' I9 r4 O1 w0 a3 z4 X; nspecific cell surface marker CD31 (also known as Pecam1)
4 K* Y7 V& m' A(supplementary material Fig. S1). By E9.5, Nkx2-5 was localized to
$ I/ Z$ g9 Q8 Vthe myocardial layer of the heart and did not overlap with EYFP
. V! V/ T0 k! h& u; f/ ~4 Y5 Kexpression (Fig. 1Q, arrowheads; compare with 1O).
8 r3 e! B2 f6 }( L ZReporter expression is mislocalized in the Er718 u6 I; |9 `! o
mutant
& b7 P; j& c1 I8 p- zIn the Er71 mutant, the hematopoietic and endothelial lineages are
* O, o$ K1 u- Wabsent. However, no changes were observed in cellular
^7 `1 w( r" x! \' xproliferation or apoptosis in the Er71 mutant embryo (Ferdous et* ?8 J5 r* x* B1 O2 m* r# b
al., 2009). Therefore, we crossed the ER71-EYFP reporter line into6 ?6 \$ F ?( B) W; g% P
the Er71 mutant background to define and characterize the cells+ u" W# j/ i4 f2 I
that should give rise to these lineages (Fig. 2). In the E7.75 wild-
9 K6 {% N8 Z: ytype embryo, EYFP expression was observed throughout the6 Z$ |( J+ C9 {
cardiac crescent, the dorsal aortae and the extra-embryonic# {# k# k, }5 Q
mesoderm (Fig. 2A). By contrast, in the E7.75 mutant embryo the
: f. T5 }' _* d6 `3 y$ J+ Vexpression pattern was less definitive. EYFP-positive cells were- d6 y" S8 N4 z/ h& }
found in the extra-embryonic tissue; however, expression of EYFP
+ f% [. [7 @7 K! P, n3 J" {within the embryo proper was mislocalized (Fig. 2B, arrow). EYFP
9 ?' a. d* ~5 z0 X1 dexpression appeared diffuse throughout the cardiac crescent (Fig.7 E) Y3 V' t) G/ c$ B/ Y
2B, asterisk). In the wild-type embryo at E8.0, EYFP expression, e5 T4 F5 d! l/ k' }3 m
was observed specifically in the dorsal aortae, but not on the6 w0 i& o6 `; A% K( C2 h
periphery of the embryo (Fig. 2C, arrowheads). EYFP expression) p) D5 n9 J1 B: V* n" K1 \
was also observed in the presumptive endocardium within the; `% e' R8 w) _) N I% ~
linear heart tube (Fig. 2C). By contrast, the Er71 mutant embryos
# d3 b6 n+ ~1 o( X; Iexpressed EYFP only at the periphery of the embryo, which is
; L' [7 K4 `) u/ q* V$ D) m% k4 rlikely to represent paraxial mesoderm (Fig. 2D).6 O3 Y. y. o A0 @% y9 t
Immunohistochemical analysis of ER71-EYFP and Pdgfra, a9 B' U: P- x8 `% S- X& Q/ K
marker of paraxial mesoderm, expression in E8.5 wild-type and& h1 m- e* z0 l! |( K, l
mutant embryos demonstrates that EYFP-positive cells are
5 A m; _4 v2 J9 u {interspersed within the Pdgfra-positive mesoderm (supplementary
7 \! \& p! [" J: y c2 T) g+ rmaterial Fig. S2). FACS profiling showed that the frequency of7 k% G( y" z: i2 {
EYFP+ cells was increased in the Er71 mutant compared with the' o, y- y, ?; L
wild-type control at E8.0 (Fig. 2G-I), but not at E7.75 (Fig. 2E,F,I).
u' Y5 E* b( r9 u" ^: i( w1 |4 _The apparent increase in the percentage of EYFP+ cells could be
8 A+ ^. Z1 _7 K/ l4 pdue to a reduction in the total number of cells without a change in, i2 q, ~- }+ V; t
the number of EYFP+ cells, as cell viability can be reduced by a6 H0 g% N) X( g0 j( A' K4 M
lack of vascularization. However, we ruled out this possibility as
# z# W; I" r7 m7 K# jwe also observed a doubling in the absolute number of EYFP+ cells
9 w6 \4 [* M1 X' I+ gin E8.0 Er71 mutant embryos as compared with wild-type
; j. h' y* \, M3 u# k- x3 \! olittermates (Fig. 2J).0 e4 v# \9 D' v) v
These analyses demonstrated that cells that expressed the ER71$ p" W7 T6 z: E2 W, \( \- l9 j c
reporter were not only present in the Er71 mutant embryo, but were6 M& q- S9 M" a! ?
also expanded in number. Since the Er71 mutant embryo lacks) d( R! [$ {( y9 d$ q
differentiated endothelial and hematopoietic lineages, we examined {! @+ w# v; v% s8 d
whether these EYFP+ cells were arrested progenitors or cells( H& N0 l4 v' A, r% z+ i/ t0 a7 e2 N8 m
redirected to other lineages. We used FACS analysis to examine the
O# k: r5 Q* f4 ^cell surface markers of the EYFP+ cells in the Er71 mutant and/ S9 w1 b& {7 v, R6 w% N$ x2 U
wild-type backgrounds. Previous studies have established that, `- t" G% r1 i, i
Pdgfra is expressed in the primitive streak at E7.0, but is restricted% Z6 t; y1 E6 o
to the paraxial mesoderm at the early head-fold stages (Takakura3 o' Y2 e; }) V, h8 D
et al., 1997). Flk1 is expressed more broadly in mesodermal, T _* `$ S; j8 R3 e% I2 i* I: o
precursors (Ema et al., 2006a; Motoike et al., 2003), including the
3 Z3 W+ l( b+ rposterior portion of the primitive streak. Flk1+/Pdgfra–
; A; b" C/ }" M; Icells mark
, {; P/ ]' d1 B% H. nlateral plate mesoderm that will give rise to the endothelial and
/ ?8 P! \& o K4 L% u8 w" S5 ihematopoietic lineages and Flk1–
. ]0 m: G' M0 s2 u' @6 j/Pdgfra+ cells mark the paraxial: M* W1 P# H# t# [
mesoderm. Flk1 and Pdgfra are known to be co-expressed in the n) M' e! C% w3 p$ d
cardiac crescent (Kataoka et al., 1997) and in cardiac progenitors7 b7 `$ X, w) |! E3 S' }* T
of embryoid bodies (EBs) (Bondue et al., 2011; Kattman et al.,: f+ b7 N# T% I3 `# e
2006). In the present study, the frequency of Flk1+ cells within the
K! ]1 o: T& [1 _& D" V) W5 E9 W8 QEYFP+ population was significantly reduced at E7.75 and E8.0
- f$ B, E, K& A$ n(Fig. 3A,B,D,F). CD41 (Fig. 3D,E) and CD34 (Fig. 3E,F)
1 x( i2 `* a t3 L9 [8 K& s& M2 hexpression was essentially absent at E8.0 in the EYFP+ cells of the$ G4 M& F( q' a3 Q7 t
Er71 mutant. These results show that the lateral plate mesoderm5 ?/ p/ F Y" ~3 |$ I) }, v: Q4 B
lineage and its derivatives, i.e. the hematopoietic and endothelial
4 `. c- H4 L& g5 elineages, are reduced in the Er71 mutant." }3 k4 _2 m: J1 r" X6 F) j
In order to assess which lineages are expressing ER71-EYFP, we$ O+ X$ H7 M5 x" Q+ q+ z
analyzed the EYFP+ cells using Flk1 and Pdgfra antibodies.
! q2 n) N4 f) wConcurrent with the decrease of Flk1 expression at E7.75 and E8.0,+ x2 X5 j2 c8 ~8 ?, K
we observed an increase in the frequency of EYFP+ cells that4 M( H: p2 s% \& O! k; D
express Pdgfra (Fig. 3A,B). This correlated with a significant
, [6 r$ i0 v o- P% tincrease of Pdgfra single-positive cells at E7.75 and a significant3 Z7 U" Y3 T3 i8 w" F( X. `
increase of Flk1+/Pdgfra+ cells at E8.0 (Fig. 3A,C). There was also) {9 h1 x! F! G5 p
a trend toward expansion of Pdgfra single-positive cells within the5 _8 m$ e z. t9 Q
EYFP+ population at E8.0 (Fig. 3A,C). To support these5 { D8 P ~- l: P, i4 \# A
observations, we used immunohistochemistry to analyze the EYFP6 z! R" T$ G4 B; }, ]7 K
expression patterns. In wild-type embryos, EYFP expression is+ D( h6 t8 h/ w \
distinct from Pdgfra+ paraxial mesoderm. A select number of+ n2 f& Z6 d4 Z0 l' X5 s$ J/ r- c
EYFP-positive cells are found within this region; however, these
r% k4 H! O S. i. n5 d" m' r2 Wcells are Pdgfra–
7 O5 z* v3 Z2 u* ], a& ~(supplementary material Fig. S2A,B). In mutant. t* k1 x# ~ o6 j5 Y0 J% i( G
RESEARCH ARTICLE Development 138 (21)
3 L6 b0 x* A d" F5 c& p" VDEVELOPMENTembryos, many EYFP+ cells are found within the Pdgfra+ paraxial
! a8 c$ G( C" { U0 ]% q; P5 w5 w6 O; fmesoderm. Some of these cells are double positive for EYFP and
$ Z6 z0 q6 z. o/ K, T8 uPdgfra (supplementary material Fig. S2C,D). Likewise, in wild-5 N- D* V5 f# f6 Z: L
type embryos, EYFP expression is distinct from troponin T (TnT)
7 ~& p4 p L1 b- D4 W* _+
) T' X4 E2 A9 g' c5 w# Dcardiomyocytes (supplementary material Fig. S2E). However, in
Z& N; f1 M8 ?; J2 y/ f& h" Tmutant embryos double-positive cells are found (supplementary
' q' Q& |: q5 J3 H0 s8 s0 Z$ `/ zmaterial Fig. S2F,G, arrows). One interpretation of these data is7 u( t. b( n7 ~" ]: }: C6 c: t |* r
that, in the absence of ER71, the EYFP+ progenitor cells
, v# F+ |* I' m5 ?% B/ Hdifferentiate towards the paraxial (Flk1–
0 b# R9 n/ J% O& N' l- i8 L3 v" s/Pdgfra+) and cardiac
+ B7 C( Z6 e5 h3 D2 z/ n7 a$ smesodermal (Flk1+/Pdgfra+) lineages at the expense of the lateral
$ c+ Z9 r# y& |/ Nplate/hemangiogenic mesodermal (Flk1+/Pdgfra–
2 @7 l# \- h" d2 @) lineage.
3 w; {: K% q0 `1 XAn alternative explanation of these results is that EYFP is; o1 e$ y6 k+ c6 V
expressed ectopically in cardiac (Flk1+/Pdgfra+) and paraxial
0 `2 { A/ H. U+ [* [. K* P(Flk1–
+ y' k4 h9 z0 E& }: p6 X! e. O. t/Pdgfra+) mesodermal populations in the absence of ER71.
9 x3 Q) T2 A0 p8 M. Y& OIf this were the case, we would expect the cardiac and paraxial
2 x4 B) [# J: b# L8 n5 ?0 m! h4 Cmesodermal populations within the EYFP–
& y8 n/ {7 A5 `gate to decrease in
8 t; t) _( [0 Ithe mutant embryos because these cells expressed EYFP and- S+ e5 f- B5 @
would be included in the EYFP+ gate. Furthermore, we would6 q% f, @. I" k& H% p) ~
expect no change in the overall representation of these markers
& R) N$ b. T$ {. Iin the unfractionated (the sum of EYFP+ and EYFP–
. ]: |3 o0 {' W0 z' }! Y) gate. To
" f3 G1 _' [' Gexamine this possibility, we analyzed unfractionated cells from$ S* n) a% ^2 E: y+ P) `
the whole embryo as well as EYFP–+ l& D; Y. h: V6 d( @. P
fractionated cells. In the
$ ^" K1 a3 S0 S9 H9 dEYFP–3 M/ M+ R, r! V! y5 z( W7 u
fraction no changes were observed in the mesodermal
; V5 T5 b7 l: n, M& F3 Hpopulations at E7.75 (supplementary material Fig. S3C,D) and, H6 P7 a+ Q d; E% B0 r! b" B) k
E8.0 (supplementary material Fig. S3G,H). Analysis of the( W, P0 B5 v k3 E% S
whole population (the sum of EYFP–0 X" f$ {% i7 m. ]/ | ?- [" q* K
and EYFP+ gates) showed
) w+ Z6 V* i* n5 o6 V& v4 h& [9 Fno change in cardiac or paraxial populations at E7.75
5 {3 M. a' _; J(supplementary material Fig. S3A,B); but at E8.0, we observed; B) c7 D$ \! J6 H" W
a small, but reproducible, increase in the cardiac mesoderm
, n. k+ ]1 O5 Q6 t+ L(Flk1+/Pdgfra+) (supplementary material Fig. S3E,F). We predict
5 s6 X* A' J2 o- M) e# G) Z, d: M; ^1 jthat the increase in cardiac mesoderm in the whole embryo is! n5 J2 c6 i% T6 d9 Y9 p+ G% F7 f
small because the EYFP+ population is a minor fraction of the/ H r4 N. O9 K# M4 ]9 o
entire embryo.% ?. B$ @. h5 {% E* d" L
Collectively, our results support the model that, in the Er71
3 \. @9 F# }3 j% }% r$ Jmutant background, EYFP+ cells differentiate to the cardiac
; b5 k% o0 L2 q; Smesoderm lineage and contribute to the increase in cardiac2 x/ J6 _: Q& |; M, v
mesoderm (Flk1+/Pdgfra+) markers, rather than cardiomyocytes or( r( n) N5 w7 C+ [5 C1 ]
cardiac progenitors ectopically expressing EYFP.% R9 P& _% }. z3 ~- u7 T8 S
4805 RESEARCH ARTICLE ER71 governs progenitor fates
/ e; _1 g- t5 K7 A; SFig. 2. The ER71 reporter is misexpressed in Er71 mutant embryos. (A-H)EYFP expression in Er71 wild type (A,C,E,G) and mutant (B,D,F,H)
0 W0 m( c" d$ {5 jmouse embryos at E7.75 (A,B,E,F) and E8.0 (C,D,G,H). Asterisks indicate the cardiac crescent (A,B) or forming linear heart tube (C,D). Arrowheads A7 Y9 W5 b7 k; V2 R
indicate the bilateral dorsal aortae (C,D) or its progenitors (A,B). Arrows point to regions in which EYFP is misexpressed in the mutant (A-D).9 c: B" J8 n" i- N% m
Representative FACS profiles of individual embryos (E-H) show the percentage of EYFP positive cells per embryo. Scale bars: 200m. (I)The
4 I& d" a7 A' _! Hpercentage of EYFP+ cells for all experiments. (J)The average number of EYFP+ cells sorted per embryo. WT, wild type; HET, Er71 heterozygote; MT,
) {. z, K+ `/ m; Z" `# S9 z; H- k! V6 `homozygous Er71 mutant. ***, P<0.001. Error bars indicate s.e.m.
: z, D) Z9 E: BDEVELOPMENT4806; O" F( M0 `! J! }: @
Cardiac and skeletal muscle genes are
+ U* Y3 L% r, I8 Y! C: Rupregulated in ER71-EYFP+ cells in Er71 mutant2 q0 U$ `* A- _( q% y" G" m
embryos
& y& ?, m; I$ C7 H, `; D, JTo further examine whether the EYFP+ cells in the absence of" _) U! @4 z3 G' @" A
ER71 were redirected to other mesodermal lineages, we performed
9 y% k \# X4 Ra transcriptome analysis. We used an Affymetrix microarray: y8 o7 X0 t; x, J# ?1 o- M
platform and examined the EYFP-positive and EYFP-negative+ z( I8 K7 E" c' V+ @9 k
cells from wild-type and Er71 mutant littermate embryos. Genes
+ ~( F$ T4 e! r) Xthat were significantly dysregulated were filtered based on the false+ u* n0 f4 ? e6 _* ?" H; e
discovery rate (FDR<0.01 for EYFP+ versus EYFP–
& S+ Z- W$ d( {6 h8 C" k: K; FDR<0.35 for E8 l3 J4 \) `/ `7 ^0 O4 `- P
wild type versus mutant; FDR<0.01 for the interaction between! H* F) y9 _ G, g6 N8 Y
these two variables). Clustering analysis was carried out6 F4 \+ N B5 H: c5 x' z+ V* v
subsequently (Fig. 4A). Interestingly, there were no transcripts that; G* `' Z4 v1 N& ]+ ]( d
showed differential expression between EYFP–/ i$ `4 c _0 {- u+ ?$ r( s2 c- `8 t( U B
populations in the
8 y( B* {$ ~, u6 M' v* S% H+ }- X. kEr71 wild-type and mutant backgrounds. Also, the cluster analysis3 Z9 F4 e1 T! h2 I/ d
was unable to resolve differences between the EYFP–2 y" a' t% b( O
populations
% [9 S) n( L/ \3 v% {0 xRESEARCH ARTICLE Development 138 (21)' Z4 ~8 b0 H5 c6 J4 r8 I! ]2 V
Fig. 3. ER71-EYFP+ cells in Er71 mutant mouse embryos lack markers of hematopoietic progenitors in exchange for those of other
3 J: \# [% r/ @; _" Jmesodermal lineages. (A)Using fluorophore-conjugated antibodies and FACS analysis, we observed an enrichment of Pdgfra+ cells in ER71-EYFP+
4 I% H/ I8 ~" G# P2 L6 @mutant cells at E7.75 and E8.0. (B,C)Summary of multiple experiments comparing individual fluorophores Flk1 and Pdgfra (B), and combinations of# z$ G0 v+ z0 e, x4 P N( q
Flk1 and Pdgfra (C). (D,F)Hematopoietic progenitor cell surface markers are not expressed in the embryo proper at E7.75, but there is a significant
+ w# S4 C+ X# c+ L: H7 R& Treduction in CD41 (D) and CD34 (F) at E8.0. (E)Summary of multiple experiments comparing hemogenic and endothelial markers CD41 and CD34.. V: g% D" Y. n& Z% R! ?
**, P<0.01; *, P<0.05. Error bars indicate s.e.m. LPM, lateral plate mesoderm; CM, cardiac mesoderm; PM, paraxial mesoderm.
" V6 Q% W7 c$ dDEVELOPMENT(Fig. 4A). These transcriptome results for the EYFP–
4 ]' m& _+ H, `4 {8 a; v3 jcells support
( ]4 v7 _1 x2 p3 | \& ~- f- `: jthe notion that EYFP is not being expressed ectopically.
0 l7 f2 ?) R C4 s2 c3 p1 T0 R3 T1 pFurthermore, this indicated that there were no significant non-cell-
: B" \1 A+ s! [" c: Bautonomous effects on gene expression resulting from the lack of
9 G# _+ D- f+ \. Z, W7 i% M5 @5 zER71 at this time point./ i+ w3 t5 h, c3 r
Within the EYFP+ populations, the Er71 mutant and wild-type
6 R/ [* m+ H$ I+ B7 m; Q5 s" g) \% Zcells were significantly different (Fig. 4A). A large number of8 |' Q; Z) D+ F: p& G3 F9 q
hematopoietic and endothelial transcripts were decreased in, [$ x, E2 I o! p, s
expression between Er71 wild-type EYFP+ and Er71 mutant
" a3 X. q( Z2 R+ K; x# CEYFP+ cells (Fig. 4C). Importantly, ER71 expression was restricted8 f) z/ N; K, ^. Z* z7 G* [" v& N
to the EYFP+ cells in the wild-type background (Fig. 4C, arrow),7 T; j7 j5 `5 a( r& @/ V9 |
confirming that the Er71-EYFP transgenic model reflects& `2 c3 K' w: w }) v/ Y3 p- y
endogenous ER71 expression. Other transcripts that were! a4 T4 i( G$ _# u2 [
downregulated in the mutant EYFP+ cells compared with the Er71
2 A$ S$ h: ]4 D4 Hwild-type EYFP+ cells included endothelial and hematopoietic2 @* t! S7 j& n* r1 V
transcripts such as Hbb-y, Fli1, Erg, Tal1, Cldn5, Cd93, Sox18,
6 V5 [, h, s" }6 R5 l; U8 \Cdh5, Sox7, Mmrn1, Eng and Nos3 (Fig. 4C). These data indicated
; F" J, b4 `0 q9 z. A3 z1 Zthat the EYFP reporter-positive cells contributed to the endothelial) [9 m% T$ d0 d# w( m& D' C
and hematopoietic lineages and did not express markers of those( F# i; ]# O6 u6 v
lineages in the absence of ER71, consistent with the previously, E. z6 y) N0 `. J6 F; {
described phenotypes (Ferdous et al., 2009; Lee et al., 2008).
( w; ~% Y8 R& q$ uTranscripts that were significantly upregulated in the Er71 mutant! d$ J. k z% Y
EYFP+ cells compared with the Er71 wild-type EYFP+ cells were' }# f- i+ f% X
associated with muscle lineages (Fig. 4B). These transcripts
, U. S! ]; \" }+ O6 Eincluded Smarcd3, Myl3, Irx4, Tnni1, Myl2 and Tbx5 (cardiac-( C H0 j* j7 `% `( b/ U
restricted transcripts); Acta1, Myl1, Svep1, Dpf3 and Cdo1 (skeletal _: o/ e7 P1 V0 R8 @
muscle-expressed transcripts); and Acta2 and Myl9 (vascular& F' V: ]* `) y2 z" O) p, B
smooth muscle-specific transcripts). These results suggested that
$ d2 w/ B {5 [6 [1 hthe EYFP+ cells gave rise to other mesodermal lineages in the0 ?- Q0 j- M4 z/ x
absence of ER71.
9 t7 V1 k7 V: [# I# _) Q/ `4 yIn order to determine whether the cardiac lineage was broadly
& Y. |# I( t% V W. [$ a1 ?" gaffected, we analyzed transcripts from the cardiac development1 c0 o0 ^* [' l1 Q5 h
gene list in gene ontology (GO) terms and performed a hierarchical* E) e: X$ C% {, U/ E4 \4 e
clustering analysis. Similar to the results obtained from whole-
" ?) P, J$ E# Hgenome analysis, wild-type EYFP+ cells segregated from the- d8 P, c( S7 \% q- f- V; m) p
mutant EYFP+ cells (and all EYFP–" @3 c) O+ d* p2 `9 x6 R3 t
cells) (supplementary material
; ^. a- Q1 i# e- ~ d5 B' L2 tFig. S4A). This result demonstrated that the difference between X& o; W$ j2 Z/ q
these two populations can also be detected based only on cardiac& t6 K1 f; n) v8 |2 p3 j
development criteria. Some transcripts were decreased in EYFP+
% h5 P; Q- P: L! g6 ~% DEr71 mutant populations compared with EYFP+ wild-type cells,4 m) A x r l& K
including a number of transcripts that are important for endocardial
' e/ e3 L* l# |6 W& @development (including Eng, Hhex, Sox18, Nfatc1, Sox17); I0 H% b% x! Z- ~0 {( `& M
(supplementary material Fig. S4B). A number of transcripts were
% | ~! p9 O7 H lincreased in expression in the EYFP+ Er71 mutant population
7 t' w) |1 N, F+ Z* ]0 `" ncompared with the other three groups (EYFP+ wild-type and both) i, n q/ |& s% X* A* ?- U
EYFP–
l$ B u5 O* q) d- e* c5 D- \populations), including a number of cardiac transcription% m2 }' v3 y2 T3 J# v2 C2 D
factors (Myocd, Nkx2-5, Irx4, Isl1, Gata6, Tbx20, Tbx5, Gata4,
7 l$ L- z) u: L# GSmyd1 and Srf) and structure-function transcripts (Myl2, Myh7,7 C2 p/ O/ e: o2 T3 y) Z
Myl3, Tnnc1, Tnnt2, Tnni3) (supplementary material Fig. S4C). We t% p* S6 A: R0 a5 ~5 j9 R) h
validated changes in selected transcripts by qPCR on independent
1 r& O& @1 a8 l/ g; r2 ?9 bsamples and confirmed decreased expression of Er71, Tal1 and g1 r$ n7 t* @- r1 }! {$ ^
Cdh5 and the overexpression of cardiac transcripts including Nkx2-
& ^/ {6 {0 T$ W4 c6 r! W7 n5, Gata4 and Tbx5 in Er71 mutant EYFP+ cells (Fig. 5).8 {9 J5 g; ?6 ` Y0 _
In summary, our transcriptome analysis indicated that cardiac
% R8 s' X- a0 |& v' tgenes are over-represented in Er71 mutant EYFP+ cells, whereas) [. P4 S( k& n5 ^5 G* F0 a
endothelial, endocardial and hematopoietic genes are under-7 G, W1 P. K b% q$ J" G9 d
represented.
7 f; Y$ j+ ]( B" Y4 ]* lA novel Er71-Cre transgene marks endothelial and) T" x8 {% D2 U8 z5 z5 {+ w
hematopoietic lineages
. | \5 H# u9 XIn order to determine whether ER71-expressing cells give rise to
# H( R) F# A4 R& z+ korgans or programs other than the endothelial and hematopoietic8 R0 `# ~2 ^" ^ c% ]
lineages, we generated an Er71-Cre transgenic mouse model (Fig.
+ a3 ]0 H# T4 @; C9 J4 P5 Q' p6A). We obtained a total of six founder lines, with embryos that
4 e1 U) q0 s. t3 ]$ r, a. [showed similar expression patterns after breeding with the Rosa-8 ]9 ~% ?8 q% `$ G8 g
4807 RESEARCH ARTICLE ER71 governs progenitor fates
8 r6 {" k: R" S, IFig. 4. Transcriptome analysis reveals that hemato-endothelial
- A" N+ {0 U0 N$ H- @and cardiac lineages are dysregulated in the Er71 mutant
# A) |6 O# \) R0 _- Rembryo. Transcriptome analysis was performed on EYFP+ and EYFP–8 Y. j$ R) \1 B* `
cells sorted from wild-type and Er71 mutant littermate mouse embryos.
2 q4 {% i% p% O% P(A)Clustering analysis shows that wild-type and mutant EYFP–+ \" X+ d; A g
cells are
- T# [+ f( k$ n- s; q) tindistinguishable, whereas EYFP+ cells from wild-type and mutant" p6 e8 p8 o. \% g
embryos show distinct gene expression profiles. (B)Transcripts
3 L8 u& F5 S x0 @7 F% q5 R( [upregulated in the EYFP+ mutant progenitors include cardiac and3 [. F; l& A& n" B) y
skeletal muscle genes. (C)Downregulated transcripts in the Er71
1 G6 ]7 U3 K# g, M* h0 Nmutant background include hemato-endothelial transcripts, including3 m$ B, D# V% ?4 t- r) l9 X6 [
Er71 (Etv2) (arrow)./ B0 o, H% F# s/ [
DEVELOPMENT4808$ O! }3 s9 e9 H/ o7 w
lacZ reporter mice (supplementary material Fig. S5). Two
$ r8 U9 ~1 U Z, I2 f; w! btransgenic lines were crossed to the Rosa-EYFP reporter mice and+ {( `5 [! O! r
used for immunohistochemical and FACS analyses. Our results# d* J& Z! q& \
revealed that E11.5 embryos were marked by Rosa-EYFP or Rosa-- S% ^6 r* M+ |) l" \6 Q/ _
lacZ in the endocardium, cardiac cushions, vasculature,) m, h" M2 _$ Y4 H$ ~6 Z1 K
mesenchyme and the fetal liver, which is the stage-appropriate site5 `' C+ v6 Q6 D( `+ R
of hematopoiesis (Fig. 6B; supplementary material Fig. S5G,H;
7 X e4 a; N) e+ Sdata not shown). Hearts of P3 neonates were marked by Rosa-% V: u, B. U8 B) C
EYFP in the vascular structures (Fig. 6C). Co-staining for EYFP/ {) W' H7 ?' ?4 |2 y/ q) O
and desmin, an early muscle-specific structural protein, showed
' Y( B7 |7 ^5 S4 [! gthat the Rosa-EYFP reporter did not overlap with desmin staining0 N2 }% ?5 V; t0 B
in the heart at either time point (Fig. 6B,C). FACS analysis of4 B& s. r/ p, _/ R8 V6 y: ?
whole E11.5 embryos showed that 7-8% of cells in the E11.5
7 M8 ~4 s, O9 F4 q; `embryo were derived from ER71-expressing cells (Fig. 6D,E). Of
# s$ s: i3 F$ N+ t `* j: O+ ]' v2 Vthese EYFP+ cells, ~12% were endothelial (CD45–
: Z. l) p! Y, g2 W2 P# N2 xCD41–, r }- v& {) `$ }
Tie2+;
! }* R s: a- u; x+ J" L) t3 mFig. 6F), 23% were non-erythroid hematopoietic cells (CD45+, also
$ Z9 v& \* s% M* w0 yRESEARCH ARTICLE Development 138 (21)6 U. a9 n5 T6 `* F
Fig. 5. Representative transcripts from the cardiac program are overexpressed in the Er71 mutant. (A-F)qPCR analysis was performed on' ]- b. _2 b, {( A+ n- v0 T
RNA isolated from EYFP+ cells in the wild-type (embryos 1 and 2) and mutant (embryos 3 and 4) backgrounds. We observed the loss of Er71 (A),, s/ h3 _, V; [) @7 l
Cdh5 (B) and Scl (C) expression and an increase in the expression of representative cardiac program transcripts including Nkx2-5 (D), Tbx5 (E), and
3 m6 ^' i+ N; nGata4 (F). Error bars indicate s.e.m.
0 j, J# V" b% Q. Y9 t$ F: X7 @- mFig. 6. Genetic fate-mapping studies indicate that ER71-expressing cells give rise to the endothelial and hematopoietic lineages.0 }3 x! k3 z, B6 u
(A)The transgenic Er71-Cre mouse model used for these studies. (B,C)Immunohistochemistry for GFP (green) and desmin (red) and DAPI staining
! N' x& }% S2 W8 C! e(blue) in E11.5 (B) and P3 (C) heart. a, atria; bw, body wall; cu, cardiac cushion; fl, fetal liver; v, ventricle. (D)A representative FACS profile showing
) |1 O+ O* {7 N9 ?0 wEYFP+ versus side scatter width (SSW). (E) ercentage of Rosa-EYFP+ cells from all experiments (n9). (F-H)EYFP-positive cells were gated and
1 I4 E8 _" v9 I4 @8 `' R6 K, Sanalyzed for lineage contribution. Representative FACS profiles are shown for (F) endothelial lineage (CD41–% ^% U9 D# N; X/ \
CD45–' S5 m9 k) d$ }! ]; Z9 x3 i+ {
Tie2+) cells and (G) CD41+
7 L+ O6 o, ]7 d) e3 MCD45+, (H) CD45+ Ter119–
F' }- m8 d8 \! ^and Ter119+ CD45–
) c; ^" [4 Y1 I8 Khematopoietic lineage cells. (I) ercentage of Rosa-EYFP+ cells of each lineage from all experiments
; v% ]$ Q% F1 ?5 @# m/ z5 l(n9). Error bars indicate s.e.m. DEVELOPMENTknown as Ptprc; Fig. 6H), and 13% were erythroid (Ter119+; also4 N+ W0 o/ |" S0 p' ]
known as Ly76; Fig. 6H). Interestingly, the EYFP+ population
. D. Z' N2 X# b3 H6 _% zsegregated into two populations of varying EYFP expression (Fig.& f7 U* M5 t$ h6 c; r
6D). Ter119 primarily marked the EYFP-low population, whereas) ]( i% b$ m# ~3 j% L
endothelial and other hematopoietic markers primarily marked the
5 Z1 }: H1 v/ ?7 \. x3 NEYFP-high population (data not shown). This suggests that the9 g3 U/ b; _) j; V2 B
Rosa reporters are expressed weakly in erythroid cells and might
n: a3 w; G* r. B2 Ltherefore inefficiently mark this population.
! Z9 [7 M. L; L" U0 cER71-EYFP-expressing cells give rise to
( @+ w) f6 W* P3 t! lmyocardium in the Er71 mutant4 w; s; |* N, I
To determine whether ER71 reporter-positive cells could produce
+ g' u, \' j. m9 D) p9 u5 @alternative lineages in the Er71 mutant, we crossed the Er71-Cre, ~/ Z/ _/ u/ x% n5 k4 I
and Rosa-EYFP alleles into the Er71 mutant background. As7 ~# V: Y' N: N4 j8 ]
observed with the ER71-EYFP reporter, Er71 mutants carrying the( v9 m0 [/ s* o' o O0 {7 m
Er71-Cre and Rosa-EYFP alleles displayed altered EYFP. a" B& E) U- @1 }% F# L
expression patterns. Compared with the Er71 wild-type embryos at
6 x, ~# n* `# ~/ [% eE8.0, in which Rosa-EYFP is expressed in the yolk sac, vessels and0 `1 ]; c1 i% {$ `* t; D
heart tube (Fig. 7A), the Er71 mutant embryos had robust EYFP. M7 C0 F' _$ a3 [
expression localized in the allantois, posterior mesoderm and
" S% y% G) s5 g( r! ^9 h* iparaxial mesoderm (Fig. 7F). We speculate that the increased. N8 `5 w9 U4 B. f9 q, T* Y% B
expression in the allantois and the posterior mesoderm is due to the1 u! E, Z* ]9 w( ^9 R* r% Z
progenitor cells differentiating to alternative mesodermal lineages,
1 e6 t6 N7 C% a1 U& Q- V4 W; kperturbed migration patterns, or a combination of the two. Embryos
0 Z5 h# P5 e: bwere analyzed using immunohistochemical techniques for co-
T! t6 Y9 v% a9 G; Mexpression of EYFP and Nkx2-5, a cardiac transcription factor,# P- L; L7 N8 U9 A: W2 r, B) c
EYFP and desmin, or EYFP and troponin T, a cardiac sarcomeric; X/ |3 r# j$ m+ k6 v5 G0 D m
protein. In wild-type hearts at E8.0, EYFP was expressed in the) \5 a9 X5 o; c
endocardium, the major vessels such as the dorsal aortae and in$ k' {7 d2 [* b- u' ^& P
hematopoietic cells within the heart (Fig. 7B-E). There was no
' W% x# L6 ]+ m; B2 ], Z" Poverlap of EYFP expression with Nkx2-5, desmin or troponin T.% @8 ]0 ^. w. c- v! I1 G& }7 M9 g3 f
In the Er71 mutant embryo, the vessels and endocardium were
# g& X' _# _( o/ X2 xabsent. However, EYFP expression persisted in the heart. In the
- A# F; O- s1 T) c3 o: oheart of the Er71 mutant embryo, all EYFP-expressing cells had an
5 Z) P# }( W. m D6 i" W) tNkx2-5-positive nucleus (Fig. 7G,H). Some of the EYFP-0 e) k$ `7 k( X1 W7 e
expressing cells were also positive for the structural proteins
, \3 G/ k+ X5 d3 ~ R5 U% ^# kdesmin and troponin T (Fig. 7I,J, arrows). These results support the
( o9 T3 Y8 @- Y- j) f6 d: `notion that the EYFP+ cells are capable of differentiating to the
0 n# X5 n$ I# c5 x2 z# Z/ s0 hmyocardial lineage in the absence of ER71. It is likely that
: C3 ` Y; G+ `progenitor cell populations are also capable of differentiating$ Z# J& E F2 O' Q4 p& H& u
toward other lineages depending on the context of the spatial and: S4 G1 L6 O6 J3 n0 u
temporal cues that they are exposed to during embryogenesis.7 D, ]1 g- D9 I1 H9 w( Q8 b
However, the heart is one of the few organs present at E8.0 and8 D: }1 @9 d( s* G/ ?* u* i+ Y) l
Er71 mutant embryos are nonviable by E9.5. Therefore, the: r( T9 |5 C9 s& Z# R
lethality of the Er71 mutant limits our ability to evaluate the
F) _3 |/ e# z- F* c# Y5 @% Xcontribution of EYFP+ progenitors to other lineages that develop7 B# g: _# B( r( S
later during embryogenesis.% u4 [ c, s) W5 [$ e
ER71 overexpression suppresses development of
$ h1 i$ q" w- h3 Jthe cardiac lineage
7 V! Q( b _3 M- S! PTo complement our analysis of the Er71 mutant embryo, we( A, W6 g1 {# y' Z3 `+ r
overexpressed ER71 using a doxycycline-inducible embryonic$ u) X4 w: H6 F6 k' q
stem cell (ES)/EB system. An ES cell line in which expression of. k4 j4 ?: v( L# S( F
ER71 can be induced by doxycycline treatment was generated by
3 {! d/ @" L3 Z) u/ Ba cassette exchange method (Iacovino et al., 2009). ES cells were
- d& _- n0 t6 W1 X% h5 v! K% Z% {! Finduced to form EBs in differentiation media and cultured for 10% o2 t- U' F N3 k0 U! U" ]# H
days with or without 0.5 mg/ml doxycycline from day 3. In the
0 f1 n- S2 J) |% C8 N1 JER71-overexpressing EBs, we observed a decrease in the/ d5 g) v2 C+ s2 R) ~
expression of troponin T, which we quantified by comparing the
- T+ X- E- e+ Ipositively stained area with the total area of the EB (Fig. 8A-E).
) K o: }2 g, z+ [ B: S8 f% yWe also observed a decrease in cardiac gene expression (Nkx2-5,$ U; c1 H7 t P, L& r' F
Tbx5 and Gata4), as quantified by qPCR analyses (Fig. 8F).
" G v& U4 [" Q/ IFinally, we quantitated the ability of the EBs to beat with edge2 t/ Q: H1 i0 y. p/ O6 L" ]3 b4 j
detection. The doxycycline-induced EBs had a dramatic reduction, |6 R6 m. S6 x5 m
in contractility (Fig. 8G) and in percent shortening (Fig. 8H).
4 f6 g; } g4 r4 U# kCollectively, these results further support the notion that ER71% c0 q9 D" Y; ^$ t7 h' D/ a0 [; ~5 ], W8 @
suppresses the myocardial fate of mesodermal progenitors.: f- i& ~5 d d/ A6 I
DISCUSSION' O: `5 j6 s/ ^' {+ Q3 W
An array of signaling cascades and networks govern the fate of
$ J: S! x0 k6 S/ G1 Q. q& Hprogenitor cell populations and their contribution to mesodermal# t/ M0 {# `7 I( \* I5 u+ W
lineages during embryogenesis. Recent studies have demonstrated' r/ @' C4 b7 K3 p
4809 RESEARCH ARTICLE ER71 governs progenitor fates7 s. f+ X. Z+ I$ T. V4 d
Fig. 7. Genetic fate-mapping studies in the Er71 mutant show that the affected lineages give rise to myocardium in vivo. (A,F)Whole-& l7 R' ^! A# ?; N# [3 e( m# Q
mount images of Rosa-EYFP expression in Er71 wild-type (A) and mutant (F) mouse embryos. The red line indicates the plane of sectioning for the
( \3 G6 i1 X, b, \; L! l' z3 `- _corresponding panels. (B,C,G,H) Immunohistochemical analysis of EYFP and Nkx2-5 shown at low (B,G) and high (C,H) magnification. (D,E,I,J)( @: p; [5 K* n/ k- U
Immunohistochemical analysis of EYFP and desmin (D,I) or troponin T (E,J) expression. ys, yolk sac; h, heart; al, allantois; da, dorsal aortae; ec,* I3 x7 B+ g4 M6 X' }' |
endocardium; mc, myocardium. Arrowheads indicate EYFP colocalization with desmin or troponin T. Scale bars: 200m in A,F; 20m in B-E,G-J., ^( Z+ W- J% |' ]! h" Z( L# d
DEVELOPMENT4810
3 o! m9 g( X% jthat various progenitors give rise to multiple mesodermal lineages.
& X% Z+ }2 e' I& K0 zThis broad developmental capacity is evident from the fact that9 B4 ]+ |: H. o8 m) \* R5 P! v
multipotent progenitors have been shown to differentiate to diverse& v3 h* X! n- v* ~
lineages, including hematopoietic, endothelial, cardiomyocyte and9 V- T; @) I1 c
smooth muscle lineages. We have previously demonstrated that
& h& `: W* b8 [4 j: e0 X- o( U; \ER71, a member of the Ets transcription factor family, is essential3 B }+ D/ T9 T" }0 O
for the development of mesodermal lineages. Er71 mutant embryos
" h+ F2 h1 a0 S9 L1 C$ l2 G: P& Zlack hematopoietic and vascular lineages and are nonviable. Here,5 q B& A5 Z8 m3 |% X
we have further defined the role of ER71 during mesodermal
/ |: L, a& W2 P. Cpatterning and have made three new discoveries that advance our
$ d# i6 k/ o, a+ A4 k8 Tmechanistic understanding of mesodermal fate decisions during' R ^/ F& m+ ~7 d
development.# ]* s- z8 ^2 x3 M. @
First, we have defined the expression pattern of ER71 during8 d$ R! u8 f0 e h
embryogenesis using a newly generated transgenic reporter
! T' ~' Y! k& ~7 @mouse model. Using immunohistochemical techniques, we
7 U5 E/ J/ d4 W mdemonstrated that ER71 is largely co-expressed with Tie2 in5 j$ N1 T& K% D1 F
endothelial and hematopoietic progenitors. In the absence of+ e9 o9 S. |4 W
ER71, we observed that these progenitors are expanded in
& M; g" _ K5 d4 g7 Hnumber but do not represent the hematopoietic and endothelial1 Q9 x$ E' a: i' i
lineages; rather, they are redirected to other mesodermal1 ]( V. p/ C6 }$ i
lineages, including the cardiac lineage. These data also show that: b( S1 W- ~& l. x
ER71 is not required for the initiation or maintenance of its own# L$ p) Y3 D. U; u4 I' s
expression. In the absence of ER71, this increase in the number
2 h1 A; ]$ {! q7 S, E' e8 mof progenitors (EYFP+ cells) might represent a delay in cell, `* [8 L# M) e" A3 H5 e
cycle withdrawal due to the lack of distinct mesodermal lineages" T# o; W! c! y
(i.e. hematopoietic and endothelial lineages) or, alternatively,
8 L- A. T. ?9 sdecreased programmed cell death involving these progenitors.2 N% l9 o3 ?; ~
We did not observe an increase in apoptosis in the Er71 mutant
( _) M2 ^8 M7 \2 m: Jembryo compared with its wild-type littermate control (Ferdous
7 ~; B$ z! y8 Set al., 2009). Thus, we hypothesize that the progenitor cell4 U, F+ q& M% d/ K
expansion in the absence of ER71 is a result of the lack of
" B- g6 f! i+ b$ Xcellular differentiation to hemato-endothelial lineages.
9 r7 V3 G' S# ]5 n3 t3 VOur second discovery defined the fate of the ER71 progenitors
) `5 R* G/ f. t& U4 Din the presence and absence of ER71. Using genetic fate-mapping
; F0 j/ o3 y1 Q0 h' Lstrategies, FACS and whole-genome analysis, we demonstrated that0 M/ C4 q: h$ ?
ER71 progenitors give rise to hematopoietic, endothelial and
/ S/ s; p' n8 S9 W6 Hmesenchymal lineages. In the Er71 mutant background, these+ _# o" `. A) Z, L1 |+ j
progenitors (EYFP+ cells) produced other mesodermal lineages,
' C: j) Y1 @1 @$ C8 e/ Lincluding the cardiomyocyte lineage (supplementary material Fig.
+ x( x7 A/ g, r3 B8 x7 v AS6). Moreover, our FACS and transcriptome data supported the
" r# {$ V% S5 X( e" ~. y$ e: @2 O; U; jnotion that paraxial mesodermal programs (transcripts enriched in, _9 ]% t: F( t+ t, P' c- V% z
the skeletal muscle lineage) were increased in the Er71 mutant
. C7 y y0 x" m+ W0 n8 s" Mprogenitors. Accumulating evidence suggests that the cardiac and- O0 [" L1 `9 p/ {
hematopoietic lineages develop from a common progenitor and that- d5 r1 y* M6 Z' @1 U# G
the specification of these lineages is inversely regulated. We
0 B' ?; V/ z. F) C' I! z' G8 Krecently demonstrated that Nkx2-5 has a dual transcriptional! p0 [9 e3 B L o
regulatory role during embryogenesis as it represses Gata1-; I# x) F8 |* T
mediated hematopoiesis and promotes cardiogenesis of the# r& u: N) k" S P6 y& m: j* M
multipotent mesodermal progenitors (Caprioli et al., 2011). The
# M( _1 |7 l8 D% \) S% Kresults of the present study further support the plasticity of the# b$ |- u9 [8 ?3 R/ F- H. j
ER71 progenitors and their capacity to respond to cues and" E; K$ y5 \+ A* N& ]6 e! M
contribute to other mesodermal lineages.
6 D0 E$ c, a" o/ ~; l& _/ JThe origin of endocardium relative to the myocardium has
% R# K' X# ]! k) R* Jbeen controversial (Harris and Black, 2010). Studies in zebrafish$ v9 h \5 V$ b% y' q1 p5 d
and chick suggest that endocardial and myocardial lineages are+ u' e* g. M6 e N. u
distinct from the point of gastrulation, and there are no
. r3 X( Q& J+ X- a, x9 omultipotent progenitors (Cohen-Gould and Mikawa, 1996; Wei6 [3 v7 p; Z4 y6 W3 w
and Mikawa, 2000). By contrast, lineage-tracing studies in
( b" t7 \+ S6 W8 y& |mouse embryos and ES cells suggest that endocardial
& V; t2 k2 }' _progenitors are specified as multipotent progenitors in the4 e) @$ A* z" h2 N: L5 J
cardiac crescent and cell fate is later specified to either
: ?3 v5 q/ a- S: G% `3 {1 l( Gendocardial, myocardial or vascular smooth muscle fates/ n: J# ^$ s/ p* U' D3 @( F9 o
(Kattman et al., 2006; Misfeldt et al., 2009). In our novel ER71-
* D1 v7 \ M, c! V- q/ _+ Q5 iEYFP reporter mice, we observed weak co-expression of Nkx2-0 |9 l0 s5 J$ N) L$ k
5 protein and EYFP in the cardiac crescent at E7.75. However,
2 N( R" _$ E/ b; `lineage-tracing experiments showed that cells that expressed7 h; d: g+ a9 \- B& |
ER71 during any point in their development did not become1 O. {, V, y# a" @- | E" L
cardiomyocytes. By contrast, Nkx2-5-Cre lineage-tracing9 c5 W D* C5 @' E
experiments show that at least some of the endocardial lineage
6 l L/ C+ r' b$ B$ yderives from cells that expressed Nkx2-5 (Stanley et al., 2002).
& L: H- |3 Q$ l8 u- M: t, fTaken together, these observations favor a model in which! T' {% t4 P& ?$ i. b* `+ E
common progenitors of endocardial and myocardial lineages are0 K( h$ P0 Q; y1 ]
specified as Nkx2-5+ cells in the cardiac crescent, but those that" s! u% D% n2 t0 X
RESEARCH ARTICLE Development 138 (21)4 z+ O% P) s! \4 \7 s
Fig. 8. Overexpression of ER71 in differentiating EBs inhibits. D) X$ `; g* N" {& z0 T7 w' m& b
cardiac development. (A-D)Sections of representative EBs either! s% `# v& w! M0 j' ^7 O9 l8 B
untreated (A,C) or induced to overexpress ER71 (B,D) stained with( n# `. A: `* G5 ~3 V! j# Y# r
Hematoxylin and Eosin (C,D) or anti-TnT (A,B). (E)Quantitative analysis of& a' s& w9 v" l
the troponin T-positive area in 33 induced (Dox) and 42 untreated
: M ^, r2 s ]) ?9 Y8 fsections. (F)qRT-PCR confirms that representative cardiac program1 u- M+ Z/ S# a
transcripts (Nkx2-5, Tbx5, Gata4) are downregulated in ER71-
# n A9 `( U Roverexpressing EBs. (G,H)Extent of contraction and relaxation after 2
* l1 O [* X0 Gseconds of stimulation (G) and percent shortening (H) are reduced in
3 o: x/ \& C `* x1 ^ER71-overexpressing EBs. ****, P<0.001; *, P<0.05. Error bars indicate- p6 a" ^9 L* U4 H$ |' I- q
s.e.m./ i4 Z `, G2 g1 f( i9 k/ M. F
DEVELOPMENTwill become endocardium will downregulate myocardial0 C% }" b: U( q9 k
potential, including the expression of Nkx2-5. Once ER71 is
# p" v% G( ^% Wexpressed, the fate is restricted to endocardium, and not3 f( f O; m1 w( ~9 C* q
myocardial lineages. Future studies are warranted to decipher the
8 r+ r3 w( |* pmechanism that governs the specification of endocardial cells
% }+ E4 H: @7 F, Lwithin the cardiac progenitor pool.0 J; Y, A$ @& B+ a- R2 y) q
Our third finding is that ER71 overexpression repressed cardiac9 c! w6 [1 C C- F# Z2 g J" u3 q
potential. These results support the notion that ER71, like Nkx2-5,
' u. j/ b G: U/ ]has reciprocal and overlapping dual roles in the specification of
% N! n+ p6 f" H2 Omesodermal lineages. Our previous studies demonstrated that5 G0 ~6 ?4 A0 J/ y! R) J! h! ?+ a- a
Nkx2-5 overexpression suppressed hematopoiesis, but not the
+ a8 v' [( W# y0 T) Kendothelial program (Caprioli et al., 2011). We further defined that
+ B5 A, p6 z+ INkx2-5 could, in a context-dependent fashion, transcriptionally
# i/ M; B& M' K4 t+ i* aactivate Er71 and promote endocardial lineage development/ t; Y) d4 M' J
(Ferdous et al., 2009). Collectively, our previous studies and recent
% s3 i1 f# g9 Z" N9 z2 qresults support the notion that distinct transcriptional networks can,
- ^7 m' y9 \" c7 X Oin a context-dependent fashion (and dependent on the local
* s5 z0 R4 ^: L8 w% M1 ?, eenvironment), activate a hematopoietic or endothelial program and. w# U g7 C8 J. g( U1 S/ N
antagonize the cardiac program. These studies further emphasize
. R. Y7 ]- ` ethe plasticity of progenitors and their contribution to distinct9 o2 p8 Z A/ K4 Z( |# q) N
lineages.- d* ~, v3 }+ e X, [; a* t
In summary, our data support a dual role for ER71 in the
2 n, C: P; Q( F, ispecification of the endothelial and hematopoietic lineages and the
& g9 V% `8 \6 O! S3 [3 L! e6 a) \suppression of other lineages (i.e. myocardial and paraxial
3 i+ e; k/ ~/ L4 Lmesodermal cell fates) (supplementary material Fig. S6). Our. ?. h; u* ]1 D1 U5 Q. _- n- F
studies further support the notion of multipotent mesodermal
4 m2 ^( `8 B; fprogenitors that are dependent on transcriptional cascades and other
H9 z8 r! W% j( }1 wcues to direct them to populate one or more lineages. Moreover,/ x7 R/ R+ `5 |; i; F
our studies reveal that global deletion of a single gene (i.e. Er71)
- _- G# ^. }9 A8 c& ], k/ d6 xaborts one or more lineages and redirects the cells to other lineages$ W" v0 e: i$ c
that would not typically arise from those progenitors. These studies2 l5 E6 R0 B, [ Q3 g! l
further our understanding of the regulatory mechanisms that govern; J* B0 o4 J7 _/ \* k# f) I4 O
mesodermal cell fate decisions and embryogenesis.
1 G4 O0 s5 d* E3 ?( LAcknowledgements8 H2 S$ w H. o) N. T
We thank Jennifer L. Springsteen and Alicia M. Wallis for assistance with7 b1 {' N3 \2 ?8 Y4 Y7 p6 @
histological analyses and animal care.
5 e5 ?9 c+ D, G) _9 X) D7 C' ZFunding3 `+ o, Y8 @% Q& w5 m" R+ A& s' P; `
Funding support was obtained from the National Institutes of Health [U012 }& P+ X5 E n
HL100407 and R01 HL085729 to D.J.G.]; and the American Heart Association
1 [) z4 c3 O" o/ Z[Jon Holden DeHaan Foundation 0970499 to D.J.G.]. Deposited in PMC for
! I/ S7 [; Y. w3 ]5 I+ T5 _. xrelease after 12 months.0 \& o' u" M/ d" x# ?1 _1 d
Competing interests statement
' ]! T% X" j3 e- d) CThe authors declare no competing financial interests.
- \2 ^/ U% [7 e1 U' L1 Q) rSupplementary material
0 c8 T/ M9 t8 F( M" K; BSupplementary material available online at% V5 g m1 h' U
http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.070912/-/DC1
: q+ ^: G6 Z2 u4 g# s, W# _References: Q1 a! O' S9 \' d1 h
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a$ G# v7 j6 t1 R; p, W" a% [
practical and powerful approach to multiple testing. J. R. Statist. Soc. B 97, 289-
; H- j+ F- {% F: @; v300.
0 x, t* J0 I. Y% X* g, e; }Bondue, A., Tannler, S., Chiapparo, G., Chabab, S., Ramialison, M.,
1 `# c' c) C/ v( |$ GPaulissen, C., Beck, B., Harvey, R. and Blanpain, C. (2011). Defining the% {/ g( c8 l8 b
earliest step of cardiovascular progenitor specification during embryonic stem, D9 P7 u$ U; l2 {! ~
cell differentiation. J. Cell Biol. 192, 751-765.
0 Y5 e U/ u$ J3 uCaprioli, A., Koyano-Nakagawa, N., Iacovino, M., Shi, X., Ferdous, A.,2 C1 u/ k7 n/ W4 h
Harvey, R. P., Olson, E. N., Kyba, M. and Garry, D. J. (2011). Nkx2-59 A' p. ?+ W9 `% r" M) `
represses Gata1 gene expression and modulates the cellular fate of cardiac4 a0 _2 s3 a" I: a A4 @
progenitors during embryogenesis. Circulation 123, 1633-1641.
* o& _9 `* B6 ~Carbon, S., Ireland, A., Mungall, C. J., Shu, S., Marshall, B. and Lewis, S.
& t" c+ ~. b5 @! K7 R) E9 c(2009). AmiGO: online access to ontology and annotation data. Bioinformatics
0 C5 d3 Z5 }' e* B; x# d! C, N4 n& l25, 288-289.- I# D; C2 B( l* X) u, i# _
Cohen-Gould, L. and Mikawa, T. (1996). The fate diversity of mesodermal cells5 n) F& e# {, Q$ P1 M M% s$ Z+ Z
within the heart field during chicken early embryogenesis. Dev. Biol. 177, 265-+ [5 V4 }1 c6 m2 x& W; J- B- K
273.
4 u3 ?/ _- `, @- v9 M5 g( {# B6 ZDavis, L. A. and Zur Nieden, N. I. (2008). Mesodermal fate decisions of a stem! s3 W( N- g3 c$ l! l
cell: the Wnt switch. Cell Mol. Life Sci. 65, 2658-2674.
; I$ C+ B* h2 {& i9 Dde Hoon, M. J., Imoto, S., Nolan, J. and Miyano, S. (2004). Open source
" \/ V5 n% g( i) Rclustering software. Bioinformatics 20, 1453-1454.$ m( {! B0 O; v2 q7 @/ h
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris,
0 |. n) b) U( }2 X+ [3 wI. S., Ehlers, M. L., Agarwal, P., Visel, A., Xu, S. M. et al. (2008).( X, N& t ~; p6 K' `
Combinatorial regulation of endothelial gene expression by ets and forkhead# s( j0 s& Z5 i7 [
transcription factors. Cell 135, 1053-1064.6 S+ ^6 |7 q0 w" a; t. J" L
Downs, K. M. and Davies, T. (1993). Staging of gastrulating mouse embryos by
2 ~( k! W2 C$ H( zmorphological landmarks in the dissecting microscope. Development 118, 1255-
' l! b3 T7 W" a3 I0 K: b( T% I1266.
$ c0 `* g* q6 F9 f! |" zDumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J. and Breitman, M.8 k! b* Q, y0 S* ^) |, r9 e
L. (1992). tek, a novel tyrosine kinase gene located on mouse chromosome 4, is
. R, H, v4 \7 G5 L0 yexpressed in endothelial cells and their presumptive precursors. Oncogene 7,
8 C p5 S- e' b$ `6 i4 Q1471-1480.
- B7 T4 F W/ \6 e& r- `' eEma, M., Takahashi, S. and Rossant, J. (2006a). Deletion of the selection0 }. M% _# W+ {2 o; x' X3 ~
cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk16 y5 D0 G+ h9 \! x" I
expression in multipotent mesodermal progenitors. Blood 107, 111-117.
/ n3 n& `) s& _. ~: H- x% vEma, M., Yokomizo, T., Wakamatsu, A., Terunuma, T., Yamamoto, M. and
- [$ @# Z( B. B% E; n- tTakahashi, S. (2006b). Primitive erythropoiesis from mesodermal precursors
& U7 ?; j7 d) _5 }expressing VE-cadherin, PECAM-1, Tie2, endoglin and CD34 in the mouse6 r9 b+ E; S( H+ l
embryo. Blood 108, 4018-4024.% N% x! u* R+ y3 |
Ferdous, A., Caprioli, A., Iacovino, M., Martin, C. M., Morris, J., Richardson,3 [& W! k' t) D* g4 r" ~/ _- W- X
J. A., Latif, S., Hammer, R. E., Harvey, R. P., Olson, E. N. et al. (2009). Nkx2-
* z- o, q. t! W1 E1 Y2 e4 `6 R1 m5 transactivates the Ets-related protein 71 gene and specifies an endothelial/' {& b- f6 T9 N: q* o
endocardial fate in the developing embryo. Proc. Natl. Acad. Sci. USA 106, , V! G# j+ @" j3 x) U
814-819.) |, h, v/ z* g0 x C; O C
Harris, I. S. and Black, B. L. (2010). Development of the endocardium. Pediatr.
4 {! u8 u$ I5 L% s9 t- n# |Cardiol. 31, 391-399.2 ]5 {, c. |( ?3 z, f. E4 g
Iacovino, M., Hernandez, C., Xu, Z., Bajwa, G., Prather, M. and Kyba, M." A) a! U, V, t( |6 r! L
(2009). A conserved role for Hox paralog group 4 in regulation of hematopoietic4 I# E/ N9 \6 l
progenitors. Stem Cells Dev. 18, 783-792.
2 k6 i' X- G; v1 i" C, @, i; mIrizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J.,( ?( ^/ l8 W& L8 H3 t
Scherf, U. and Speed, T. P. (2003). Exploration, normalization and summaries4 ~$ d, X, i# b) {5 h+ N
of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
& f9 e% Y5 F2 q {* _# Z) `7 R( x, ^Ivey, K. N., Muth, A., Arnold, J., King, F. W., Yeh, R. F., Fish, J. E., Hsiao, E. C.,5 p9 W7 Q5 P4 N
Schwartz, R. J., Conklin, B. R., Bernstein, H. S. et al. (2008). MicroRNA
$ y: L- ^8 Q0 y5 p* W. Gregulation of cell lineages in mouse and human embryonic stem cells. Cell Stem s9 @5 X1 i1 N" [3 b
Cell 2, 219-229.
$ u+ K0 ^0 r1 z* n' R7 PKataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama, H.,
9 ]# p- X8 s! C& y# R' I5 UKunisada, T., Risau, W., Kita, T. and Nishikawa, S. I. (1997). Expressions of
: [# E: n6 k2 @0 }1 l- l6 i8 bPDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 52 S. e1 Y. u" j: p" _; P$ S4 w
define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 39, 729-& R) C; w3 |5 T' |' q
740.2 k# K4 j& h( M
Kattman, S. J., Huber, T. L. and Keller, G. M. (2006). Multipotent flk-1+
7 B, k9 J+ U' ?. O. Dcardiovascular progenitor cells give rise to the cardiomyocyte, endothelial and: z4 g1 a- _* L! I6 }# }& G7 E0 ~
vascular smooth muscle lineages. Dev. Cell 11, 723-732.0 D; T0 x3 E1 B
Kaufman, M. H. (1992). The Atlas of Mouse Development. London: Academic) }0 p& O( M& s. J1 g
Press.
0 }" K4 }$ u1 U u3 W# F) IKennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N. and0 _' r) r K1 Q H
Keller, G. (1997). A common precursor for primitive erythropoiesis and
7 P* @) c4 o) C: g5 M0 J0 Z7 Ldefinitive haematopoiesis. Nature 386, 488-493.
/ T0 o, `, i0 U y$ \2 f) d: Q JKisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson, J. A.
+ v3 w9 F: m* }: _* Y) T, O0 e) x& Kand Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for
- o' m/ |- ?* r4 A; n7 `5 uendothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
' y7 x5 K) _) XLee, D., Park, C., Lee, H., Lugus, J. J., Kim, S. H., Arentson, E., Chung, Y. S.,' q; c8 o8 t) H4 `
Gomez, G., Kyba, M., Lin, S. et al. (2008). ER71 acts downstream of BMP,2 Y- m8 m- y, w X8 }. ~
Notch and Wnt signaling in blood and vessel progenitor specification. Cell Stem
$ B; D+ i0 f6 z7 XCell 2, 497-507.
- R& R: i, D7 }7 Z/ r6 w5 wLi, W., Ferkowicz, M. J., Johnson, S. A., Shelley, W. C. and Yoder, M. C.. v9 o0 a6 F( ^: G1 X
(2005). Endothelial cells in the early murine yolk sac give rise to CD41-expressing
2 r0 L9 R# ~9 {8 xhematopoietic cells. Stem Cells Dev. 14, 44-54.
4 C! i% G3 z( I4 o) I+ AMisfeldt, A. M., Boyle, S. C., Tompkins, K. L., Bautch, V. L., Labosky, P. A. and
. Z6 c0 n- O1 ?) H& aBaldwin, H. S. (2009). Endocardial cells are a distinct endothelial lineage# q* W6 [) Y4 C$ `5 P/ Y3 n' B
derived from Flk1+ multipotent cardiovascular progenitors. Dev. Biol. 333, 78-% d! i# `2 p/ u+ g# w& V
89.
- D/ {; b. @9 DMoretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y.,/ [& [9 \. J! H
Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S. et al. (2006). Multipotent
: d1 w; m! G oembryonic isl1+ progenitor cells lead to cardiac, smooth muscle and endothelial
8 @& p% r; |: R D+ ^" k: Ucell diversification. Cell 127, 1151-1165., s$ l, E- d" x" q1 _
Motoike, T., Markham, D. W., Rossant, J. and Sato, T. N. (2003). Evidence for
& a8 Q3 U5 [; ~3 Cnovel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis 35, 153-5 @$ q# [0 ~6 w+ I5 p. G: u0 Q# R2 `
159.
# A9 O6 N$ j# rOmelyanchuk, N., Orlovskaya, I. A., Schraufstatter, I. U. and Khaldoyanidi,4 `) `7 I: ?1 _; n
S. K. (2009). Key players in the gene networks guiding ESCs toward mesoderm.' @* m E$ [+ p
J. Stem Cells 4, 147-160.# ]* Q$ P7 Q: X- J
Park, M., Yaich, L. E. and Bodmer, R. (1998). Mesodermal cell fate decisions in0 u- J/ p; g2 w
Drosophila are under the control of the lineage genes numb, Notch and7 ?) V( I4 T' _1 s+ g T$ e
sanpodo. Mech. Dev. 75, 117-126.
& P: `/ y) }- @) p E4811 RESEARCH ARTICLE ER71 governs progenitor fates/ ^; @2 L0 O. _ }6 b$ ]1 n% c9 z
DEVELOPMENT48123 R# O2 J- d# b: W* I2 J
Sarb, S., Cimpean, A. M. and Grigoras, D. (2010). Tie2 expression in human4 `+ M. i# Y+ r; j T: y
embryonic tissues. Rom. J. Morphol. Embryol. 51, 81-84.# G. N" S& p. ]: h+ s
Schlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W.,/ B q: p/ m; q4 X% G/ u
Deutsch, U. and Sato, T. N. (1997). Uniform vascular-endothelial-cell-specific
; g% o; v# W( Q0 \$ h' D; V1 tgene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad.
( X- L1 d: h' \7 L" V! tSci. USA 94, 3058-3063.& {& @+ `+ \. i
Schnurch, H. and Risau, W. (1993). Expression of tie-2, a member of a novel
/ u% z, l# D* Q( cfamily of receptor tyrosine kinases, in the endothelial cell lineage. Development
! R( `3 A8 V3 L1 E- u3 l; q0 x119, 957-968.
, V# V/ ^) \+ `" {Smyth, G. (2005). limma: linear models for microarray data. In Bioinformatics and
# l+ F% p; B# X0 U% [7 @- s% _Computational Biology Solutions Using R and Bioconductor (ed. V. J. C. Robert
3 \: `2 Q8 `! ZGentleman, W. Huber, R. A. Irizarry and S. Dudoit), pp. 397-420. New York:
8 U! w- w. e# G3 rSpringer.4 j% _4 C0 y& E6 L+ o
Stanley, E. G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L. and
8 ~. v- ^5 y4 s9 L5 O: B7 G YHarvey, R. P. (2002). Efficient Cre-mediated deletion in cardiac progenitor cells
5 F. r: T4 v6 B; c& c- y8 I2 J5 dconferred by a 3UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev.
. W ~9 U6 a8 W8 ~1 B1 Z+ ^Biol. 46, 431-439.' R' v5 B( R' B8 C; `( _2 p
Takakura, N., Yoshida, H., Ogura, Y., Kataoka, H. and Nishikawa, S. (1997).
. h1 {8 j' x7 ?: I. k# l, p; MPDGFR alpha expression during mouse embryogenesis: immunolocalization
3 D# |" d2 e+ G7 w5 Canalyzed by whole-mount immunohistostaining using the monoclonal anti-! W' R3 U, N* }9 V3 K, e
mouse PDGFR alpha antibody APA5. J. Histochem. Cytochem. 45, 883-893.
/ W$ P& i! ?7 r: F3 kWei, Y. and Mikawa, T. (2000). Fate diversity of primitive streak cells during heart. ^& K( B$ l2 H0 `
field formation in ovo. Dev. Dyn. 219, 505-513.
$ V- u* C! P( t8 P& x* \6 uWu, S. M., Fujiwara, Y., Cibulsky, S. M., Clapham, D. E., Lien, C. L.,
- q' T) ^, ~- R" L6 T9 [Schultheiss, T. M. and Orkin, S. H. (2006). Developmental origin of a# i- W; ^6 Q# C' H
bipotential myocardial and smooth muscle cell precursor in the mammalian
6 _* @( T6 f0 k. ?$ Theart. Cell 127, 1137-1150.
7 \! u0 y- W) g7 LRESEARCH ARTICLE Development 138 (21)
8 `& i; j. E/ E$ T WDEVELOPMENT |
-
总评分: 包包 + 5
查看全部评分
|